var title_f21_18_21792="AC joint OA post trauma";
var content_f21_18_21792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Post-traumatic arthritis of the AC joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiograph above shows degeneration of the acromioclavicular joint that developed following trauma. Note the widened joint space and lucent distal clavicle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21792=[""].join("\n");
var outline_f21_18_21792=null;
var title_f21_18_21793="Necrotizing gingivitis";
var content_f21_18_21793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrotizing ulcerative gingivitis in a 3-year-old child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The gingival lesion/inflammation involves the mandibular incisors in a malnourished child with poor oral hygiene.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Enwonwu, CO, Phillips, RS, Savage, KO. Inflammatory cytokine profile and circulating cortisol levels in malnourished children with necrotizing ulcerative gingivitis. Eur Cytokine Netw 2005; 16:240. Copyright &copy; 2005 John Libbey Eurotext.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21793=[""].join("\n");
var outline_f21_18_21793=null;
var title_f21_18_21794="4 chamber view showing circumferential pericardial effusion";
var content_f21_18_21794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57021&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    4 chamber view showing circumferential pericardial effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The apical four chamber view shows a moderate to large anterior and posterior pericardial effusion (PE), but the curvature of the right atrium (RA) is normal. In panel B there is diastolic expiratory invagination, compression, or collapse of the RA. Collapse of the right atrium is a highly sensitive, but relatively nonspecific, sign of hemodynamically important tamponade. More importantly, the left atrium (LA) also appears compressed. This latter sign is felt to be more specific for tamponade.",
"    <div class=\"footnotes\">",
"     RV: right ventricle; LV: left ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21794=[""].join("\n");
var outline_f21_18_21794=null;
var title_f21_18_21795="Deep retinal hemorrhages";
var content_f21_18_21795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Deep retinal hemorrhages",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 416px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Deep retinal hemorrhages are small, rounded, slightly irregular red spots that are sometimes called dot or blot hemorrhages. They occur in a deeper layer of the retina than flame-shaped hemorrhages.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bickley, LS and Szilagyi, P. Bates' Guide to Physical Examination and History Taking, 8th Ed. Philadelphia: Lippincott Williams &amp; Wilkins 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21795=[""].join("\n");
var outline_f21_18_21795=null;
var title_f21_18_21796="Left vocal fold polyp A";
var content_f21_18_21796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64623%7EPC%2F77614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64623%7EPC%2F77614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left vocal fold polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These can occur secondary to acute vocal fold trauma (such as yelling) with hemorrhage into the vocal fold and subsequent edema and fibrosis. Excision is often required.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left vocal fold polyp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Identified in an elderly woman with longstanding hoarseness. The polyp is large enough to ball valve into the subglottic airway with inspiration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21796=[""].join("\n");
var outline_f21_18_21796=null;
var title_f21_18_21797="Trimipramine: Patient drug information";
var content_f21_18_21797=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Trimipramine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31271?source=see_link\">",
"     see \"Trimipramine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F231670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Surmontil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F231671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Trimip&reg;;",
"     </li>",
"     <li>",
"      Nu-Trimipramine;",
"     </li>",
"     <li>",
"      Rhotrimine&reg;;",
"     </li>",
"     <li>",
"      Surmontil&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to trimipramine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703749",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had a recent heart attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702396",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to linezolid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an overactive thyroid, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695854",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime if it causes sleepiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11126 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21797=[""].join("\n");
var outline_f21_18_21797=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231670\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F231671\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021632\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021634\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021633\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021638\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021639\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021641\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021636\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021637\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021642\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021643\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31271?source=related_link\">",
"      Trimipramine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_18_21798="Valganciclovir: Pediatric drug information";
var content_f21_18_21798=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Valganciclovir: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?5/37/5718?source=see_link\">",
"    see \"Valganciclovir: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19925?source=see_link\">",
"    see \"Valganciclovir: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F232941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Valcyte&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F232942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Valcyte&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2797950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiviral Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Valganciclovir tablets and ganciclovir capsules cannot be substituted on a mg-per-mg basis since they are",
"     <b>",
"      NOT BIOEQUIVALENT.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PNA &gt;7 days: 16 mg/kg/dose every 12 hours; a pharmacokinetic study of 24 neonates demonstrated that 16 mg/kg/dose twice daily produced similar serum concentrations to ganciclovir 6 mg/kg intravenously twice daily (Acosta, 2007; Kimberlin, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F2797981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/37/5718?source=see_link\">",
"      see \"Valganciclovir: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Valganciclovir tablets and ganciclovir capsules cannot be substituted on a mg-per-mg basis since they are",
"     <b>",
"      NOT BIOEQUIVALENT.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants 1-3 months of age: 16 mg/kg/dose every 12 hours; a pharmacokinetic study of 24 neonates demonstrated that 16 mg/kg/dose twice daily produced similar serum concentrations to ganciclovir 6 mg/kg intravenously twice daily; treatment course extended into the infant period and can be considered for this population (Acosta, 2007; Kimberlin, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants, Children, and Adolescents 4 months to 16 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Manufacturer's recommendations:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Prevention of CMV disease following kidney or heart transplantation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Once daily dose (mg) = 7 x body surface area x creatinine clearance*",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Begin therapy within 10 days of transplantation; continue therapy until 100 days post-transplantation. Doses should be rounded to the nearest 25 mg increment; maximum dose: 900 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     * Cl",
"     <sub>",
"      cr",
"     </sub>",
"     (mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     ) = [k x height (cm)] &divide; serum creatinine (mg/dL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     <b>",
"      Note:",
"     </b>",
"     If the calculated Cl",
"     <sub>",
"      cr",
"     </sub>",
"     is &gt;150 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     , then a maximum value of 150 mL/minute/1.73 m",
"     <sup>",
"      2",
"     </sup>",
"     should be used to calculate the dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Calculated using a",
"     <i>",
"      modified",
"     </i>",
"     Schwartz formula where k =",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     &bull;	0.45 in patients &lt;2 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     &bull;	0.55 in boys age 2 to &lt;13 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     &bull;	0.55 in girls age 2-16 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     &bull;	0.7 in boys age 13-16 years",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Alternate dosing: Limited information available: 15-18 mg/kg/day once daily for the first 100 days post liver transplant in patients considered low-risk for CMV disease reported by one center for the prevention of CMV disease following transplantation (Clark, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adolescents &gt;16 years and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     CMV retinitis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Induction: 900 mg twice daily for 21 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Maintenance: Following induction treatment or for patients with inactive CMV retinitis who require maintenance therapy: 900 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Prevention of CMV disease following transplantation: 900 mg once daily beginning within 10 days of transplantation; continue therapy until 100 days (heart or kidney-pancreas transplant) or 200 days (kidney transplant) post-transplantation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants, Children, and Adolescents 4 months to 16 years: No additional dosage adjustments required; use of equation adjusts for renal function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents &gt;16 years and Adults (tablet formulation):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Induction dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     40-59 mL/minute: 450 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     25-39 mL/minute: 450 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-24 mL/minute: 450 mg every 2 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     40-59 mL/minute: 450 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     25-39 mL/minute: 450 mg every 2 days",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:10em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-24 mL/minute: 450 mg twice weekly",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Valganciclovir is not recommended in patients receiving hemodialysis. For patients on hemodialysis (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute), it is recommended that ganciclovir be used instead of  valganciclovir with dose adjusted as specified for ganciclovir.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Use has not been studied.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F232917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valcyte&reg;: 50 mg/mL (100 mL) [contains sodium benzoate; tutti frutti flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valcyte&reg;: 450 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F232903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2797982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Administer with meals.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F2797958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral solution: Store dry powder at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Prior to dispensing, prepare the oral solution by adding 91 mL of purified water to the bottle; shake well. Store oral solution under refrigeration at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze. Discard any unused medication after 49 days. A reconstituted 100 mL bottle will only provide 88 mL of solution for administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablets: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2797951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention of CMV disease in high-risk patients undergoing heart or kidney transplantation (FDA approved in ages 4 months to 16 years and adults); treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) (FDA approved in adults); prevention of CMV disease in high-risk patients (donor CMV positive/recipient CMV negative) undergoing kidney/pancreas transplantation (FDA approved in adults); has also been used for prevention of CMV disease in high-risk pediatric patients undergoing BMT or hematopoietic stem cell transplant, solid organ transplants other than those indicated above, and congenital CMV disease  (Acosta, 2007; Galli, 2007; Lombardi, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F232970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Valcyte&reg; may be confused with Valium&reg;, Valtrex&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ValGANciclovir may be confused with valACYclovir",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F232968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema, hyper-/hypotension, peripheral edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, confusion, depression, dizziness, fatigue, fever, hallucination, headache, insomnia, pain, paresthesia, peripheral neuropathy, psychosis, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, dermatitis, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration, hyperglycemia, hyper-/hypokalemia, hypocalcemia, hypomagnesemia, hypophosphatemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distention/pain, appetite (decreased), constipation, diarrhea, dyspepsia, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, aplastic anemia, bleeding (potentially life-threatening due to thrombocytopenia), bone marrow depression, neutropenia, pancytopenia,",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Ascites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, limb pain, muscle cramps, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Retinal detachment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Creatinine clearance (decreased), dysuria, renal impairment, serum creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, dyspnea, nasopharyngitis, pharyngitis, pleural effusion, rhinorrhea, upper respiratory tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, local and systemic infection (including sepsis)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Valganciclovir is expected to share the toxicities which may occur at a low incidence or due to idiosyncratic reactions which have been associated with ganciclovir",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2797953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to valganciclovir, ganciclovir, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F2797999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The bioavailability of ganciclovir from valganciclovir tablets is significantly higher than with ganciclovir capsules; valganciclovir tablets cannot be substituted for ganciclovir capsules on a one-to-one basis. In pediatric patients, the preferred dosage form is oral solution; however, if calculated dose is within 10% of the lowest tablet strength (450 mg), then valganciclovir tablets may be used for doses. Use with caution in patients with pre-existing bone marrow suppression, cytopenias, or in those patients receiving myelosuppressive drugs or irradiation; adjust dose or interrupt valganciclovir therapy in patients with neutropenia and/or thrombocytopenia. Use with caution and modify dosage in patients with impaired renal function or in patients receiving concomitant nephrotoxic drugs; maintain adequate hydration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Oral solution contains sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; use oral solution containing sodium benzoate with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2797954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . May cause dose- or therapy-limiting granulocytopenia, anemia, and/or thrombocytopenia",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; do not use if ANC &lt;500 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     , platelets &lt;25,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , or hemoglobin &lt;8 g/dL. Valganciclovir is converted to ganciclovir and shares its reproductive toxicity. Animal studies have demonstrated carcinogenic and teratogenic effects, inhibition of spermatogenesis, and impairment of fertility with ganciclovir",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Due to its teratogenic potential, contraceptive precautions need to be followed during and for at least 30 days after therapy for women and 90 days after therapy for men. Studies in liver transplant patients reported a higher incidence of tissue-invasive CMV with valganciclovir relative to oral ganciclovir.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F232911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imipenem: Ganciclovir-Valganciclovir may enhance the adverse/toxic effect of Imipenem. May increase risk of seizures.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: May increase the serum concentration of Ganciclovir-Valganciclovir. Ganciclovir-Valganciclovir may increase the serum concentration of Mycophenolate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Ganciclovir-Valganciclovir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reverse Transcriptase Inhibitors (Nucleoside): Ganciclovir-Valganciclovir may enhance the adverse/toxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Hematologic toxicity is of specific concern.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Stavudine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tenofovir: May increase the serum concentration of Ganciclovir-Valganciclovir. Ganciclovir-Valganciclovir may increase the serum concentration of Tenofovir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F2797957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     High fat meal may increase AUC by 30%.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F232913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F232925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Valganciclovir is converted to ganciclovir and shares its reproductive toxicity.",
"     <b>",
"      [U.S. Boxed Warning]: Ganciclovir may be teratogenic and cause aspermatogenesis.",
"     </b>",
"     Based on animal data, temporary or permanent impairment of fertility may occur in males and females. Ganciclovir is also teratogenic in animals. Females should use effective contraception during treatment and for 30 days after; males should use barrier contraception during treatment and for 90 days after.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2797983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Retinal exam at least every 4-6 weeks; CBC with differential, platelet count, serum creatinine",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2797959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Valganciclovir is rapidly converted to ganciclovir in the body. The bioavailability of ganciclovir from valganciclovir is increased 10-fold compared to oral ganciclovir. A dose of 900 mg achieved systemic ganciclovir exposure comparable to that achieved with the recommended 5 mg/kg doses of intravenous ganciclovir. Ganciclovir is phosphorylated to a substrate which competitively inhibits the binding of deoxyguanosine triphosphate to DNA polymerase resulting in inhibition of viral DNA synthesis.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2797960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed; high-fat meal increases AUC by 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : Ganciclovir: 0.7 L/kg; distributes to most body fluids, tissues, and organs including CSF, ocular tissue, and brain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Ganciclovir: 1% to 2%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Prodrug converted to ganciclovir by intestinal mucosal cells and hepatocytes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 60% (with food)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Ganciclovir:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     In either healthy or HIV-positive/CMV-positive patients: 4.08 hours; prolonged with renal impairment (up to 68 hours with severe renal impairment): 4.08 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     In heart, kidney, kidney-pancreas, or liver transplant patients: 6.48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Ganciclovir: 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Majority (80% to 90%) excreted as ganciclovir in the urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: 50% removed by a 4-hour hemodialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F2797984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19925?source=see_link\">",
"      see \"Valganciclovir: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Valganciclovir is not a cure for CMV retinitis. Regular follow-up ophthalmologic exams are necessary. For oral administration, take with food and maintain adequate fluid hydration. Swallow tablets whole; do not break or crush. Avoid handling broken or crushed tablets and oral solution. Wash area thoroughly if contact occurs. Report fever, chills, unusual bleeding or bruising, infection, or unhealed sores or white plaques in mouth. Male patients and female patients of childbearing potential need to follow contraceptive precautions during and for at least 3 months after therapy with valganciclovir.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F10893687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent: Use appropriate precautions for handling and disposal.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Commercial preparation is available (50 mg/mL)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 60 mg/mL oral suspension may be with tablets and a 1:1 mixture of Ora-Sweet&reg; and Ora-Plus&reg;. Crush sixteen 450 mg tablets and reduce to a fine powder. Add 1 mL portions of chosen vehicle (10 mL total) and mix to a uniform paste; mix while adding the vehicle in incremental proportions to",
"     <b>",
"      almost",
"     </b>",
"     120 mL; transfer to a calibrated amber glass bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 120 mL. Label \"shake well\" and \"refrigerate\". Stable for 35 days refrigerated.",
"    </p>",
"    <div class=\"reference\">",
"     Henkin CC, Griener JC, and Ten Eick AP, \"Stability of Valganciclovir in Extemporaneously Compounded Liquid Formulations,\"",
"     <i>",
"      Am J Health Syst Pharm",
"     </i>",
"     , 2003, 60(7):687-90.",
"     <span class=\"pubmed-id\">",
"      12701551",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Acosta EP, Brundage RC, King JR, et al, \"Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation,\"",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 2007, 81(6):867-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/17392728/pubmed\" id=\"17392728\" target=\"_blank\">",
"        17392728",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Burri M, Wiltshire H, Kahlert C, et al, \"Oral Valganciclovir in Children: Single Dose Pharmacokinetics in a Six-Year-Old Girl,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2004, 23(3):263-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/15014306/pubmed\" id=\"15014306\" target=\"_blank\">",
"        15014306",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf%20\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clark BS, Chang IF, Karpen SJ, et al, \"Valganciclovir for the Prophylaxis of Cytomegalovirus Disease in Pediatric Liver Transplant Recipients,\"",
"      <i>",
"       Transplantation",
"      </i>",
"      , 2004, 77(9):1480.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/15167619/pubmed\" id=\"15167619\" target=\"_blank\">",
"        15167619",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Galli L, Novelli A, Chiappini E, et al, \"Valganciclovir for Congenital CMV Infection: A Pilot Study on Plasma Concentration in Newborns and Infants,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2007, 26(5):451-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/17468661/pubmed\" id=\"17468661\" target=\"_blank\">",
"        17468661",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kimberlin DW, Acosta EP, S&aacute;nchez PJ, et al, \"Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease,\"",
"      <i>",
"       J Infect Dis",
"      </i>",
"      , 2008, 197(6):836-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/18279073/pubmed\" id=\"18279073\" target=\"_blank\">",
"        18279073",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lombardi G, Garofoli F, Villani P, et al, \"Oral Valganciclovir Treatment in Newborns With Symptomatic Congenital Cytomegalovirus Infection,\"",
"      <i>",
"       Eur J Clin Microbiol Infect Dis",
"      </i>",
"      , 2009, 28(12):1465-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/19763643/pubmed\" id=\"19763643\" target=\"_blank\">",
"        19763643",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Peyriere H, Jeziorsky E, Jalabert A, et al, \"Neurotoxicity Related to Valganciclovir in a Child With Impaired Renal Function: Usefulness of Therapeutic Drug Monitoring,\" Ann Pharmacother, 2006, 40(1):143-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/18/21798/abstract-text/16368917 /pubmed\" id=\"16368917 \" target=\"_blank\">",
"        16368917",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13002 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.12-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21798=[""].join("\n");
var outline_f21_18_21798=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708869\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232941\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232942\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797950\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445213\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797981\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232917\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232903\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797982\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797958\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797951\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232970\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232968\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797953\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797999\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797954\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300203\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232911\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797957\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232913\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232925\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797983\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797959\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797960\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2797984\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10893687\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13002\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13002|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/37/5718?source=related_link\">",
"      Valganciclovir: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19925?source=related_link\">",
"      Valganciclovir: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_18_21799="Metformin poisoning";
var content_f21_18_21799=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Metformin poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Jason Chu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Andrew Stolbach, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21799/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/18/21799/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal individuals, fasting plasma glucose levels range from about 60 to 100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/1\">",
"     1",
"    </a>",
"    ]. In patients with diabetes mellitus, insulin deficiency or insulin resistance leads to a state of hyperglycemia. Galega officinalis (goat's rue or French lilac) was used to treat diabetes in medieval Europe. The active ingredient,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/5/31826?source=see_link\">",
"     guanidine",
"    </a>",
"    , was used to synthesize other antidiabetic agents in the 1920s [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/2\">",
"     2",
"    </a>",
"    ], and the biguanide hypoglycemic agents phenformin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    became available for clinical use in the 1950s.",
"   </p>",
"   <p>",
"    Biguanides are antihyperglycemic agents, not hypoglycemic agents; they promote euglycemia but alone are unlikely to cause hypoglycemia. Biguanides are used both as monotherapy and in combination with other oral hypoglycemic agents. They can exacerbate hypoglycemia caused by other types of antidiabetic medicines [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major toxicity from acute or chronic biguanide use is lactic acidosis. The high rate of severe lactic acidosis from phenformin led to the withdrawal of this drug from the US market in 1976, although it remains available in several countries.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    is the principal biguanide in clinical use.",
"   </p>",
"   <p>",
"    The management of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    toxicity is reviewed here. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68482 \" href=\"UTD.htm?21/32/22028\">",
"     table 1",
"    </a>",
"    ). General issues relating to hypoglycemia, the therapeutic use of biguanides, and the general clinical management of drug intoxication are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"     \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link\">",
"     \"Metformin in the treatment of diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    decreases insulin resistance, decreases hepatic glucose output, and enhances peripheral glucose uptake [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/5\">",
"     5",
"    </a>",
"    ]. Proposed mechanisms of action include enhanced suppression of gluconeogenesis by insulin, reduced glucagon-stimulated gluconeogenesis, and increased uptake of glucose by muscle and adipose cells [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/5\">",
"     5",
"    </a>",
"    ]. The net effects of these changes in diabetic patients are to decrease fasting and post-prandial blood glucose by 20 to 40 percent, decrease hemoglobin A1C, decrease body weight slightly, decrease low density lipoprotein (LDL), and increase high density lipoprotein (HDL) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=see_link\">",
"     \"Metformin in the treatment of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     KINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    absorption occurs primarily in the upper part of the intestine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/7\">",
"     7",
"    </a>",
"    ]. The drug has negligible plasma protein binding and a volume of distribution ranging from 63 to 276 L [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The elimination half-life of metformin in patients who take multiple doses and have good renal function is approximately five hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/7\">",
"     7",
"    </a>",
"    ]. Metformin is excreted unmetabolized from the kidneys and may accumulate in renal failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major toxicity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    is lactic acidosis, although it can contribute to hypoglycemia when in combination with other hypoglycemic drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Lactic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanism of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    -associated lactic acidosis is complex. Metformin promotes the conversion of glucose to lactate in the splanchnic bed of the small intestine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/8\">",
"     8",
"    </a>",
"    ]. Metformin also inhibits hepatic gluconeogenesis from lactate, pyruvate, and alanine, resulting in additional lactate and substrate for lactate production [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of acute overdose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    -associated lactic acidosis rarely develops in patients without comorbidities such as renal or hepatic insufficiency or acute infection. A systematic review found the incidence of such lactic acidosis to be fewer than 5.1 cases per 100,000 patient years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3781?source=see_link&amp;anchor=H6#H6\">",
"     \"Causes of lactic acidosis\", section on 'Diabetes mellitus and metformin'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A case series of 49",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    -treated patients who developed lactic acidosis reported a mortality rate of 45 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/11\">",
"     11",
"    </a>",
"    ]. Neither arterial lactate levels nor plasma metformin concentrations predicted mortality. Death in these patients more closely correlated with underlying comorbid conditions. Another case series of 42 patients reported a mortality rate of 48 percent among patients with unintentional metformin poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/12\">",
"     12",
"    </a>",
"    ]. In this study, the most accurate predictor of death was liver dysfunction, as demonstrated by an elevated prothrombin time.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    -associated lactic acidosis may also occur following acute overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/13-18\">",
"     13-18",
"    </a>",
"    ]. In one case series, 11 of 13 patients with an acute overdose had elevated lactate levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/19\">",
"     19",
"    </a>",
"    ]. A systematic review of studies involving confirmed acute metformin overdose found that lower serum pH and higher serum lactate concentrations correlated with increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/20\">",
"     20",
"    </a>",
"    ]. In this review, all 16 survivors had a serum pH above 6.9 and a serum lactate below 25",
"    <span class=\"nowrap\">",
"     mmol/L,",
"    </span>",
"    while 5 of the 6 patients with a pH below 6.9 or a lactate above 25",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    died.",
"   </p>",
"   <p>",
"    Because reports of dosages in overdose are often unreliable, it is unclear what minimum dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    leads to toxicity. The clinician should have a high index of suspicion for toxicity in children who ingest more than one or two tablets, anyone who presents with intentional overdose, and patients with comorbidities such as renal insufficiency, liver disease, or heart failure.",
"   </p>",
"   <p>",
"    Clinically significant lactic acid accumulation almost always occurs in the presence of comorbid conditions, such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal insufficiency (serum creatinine concentration above 1.4",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [124",
"      <span class=\"nowrap\">",
"       &micro;mol/L]",
"      </span>",
"      in women and 1.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [132",
"      <span class=\"nowrap\">",
"       &micro;mol/L]",
"      </span>",
"      in men), or low creatinine clearance.",
"     </li>",
"     <li>",
"      Concurrent liver disease or alcohol abuse",
"     </li>",
"     <li>",
"      Heart failure",
"     </li>",
"     <li>",
"      History of lactic acidosis",
"     </li>",
"     <li>",
"      Decreased tissue perfusion or hemodynamic instability",
"     </li>",
"     <li>",
"      Hypoxic states or serious acute illness",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     HISTORY AND PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the setting of acute overdose, clinicians should seek information about dose and coingestants, although such information is frequently unreliable. Whether the patient has an acute overdose or chronic toxicity, clinicians should also ask whether other antidiabetic agents are used.",
"   </p>",
"   <p>",
"    Patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    overdose may complain of nausea and abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/14,18,21\">",
"     14,18,21",
"    </a>",
"    ]. Physical examination findings may include tachycardia, hypotension, and tachypnea in patients with severe lactic acidosis. Alterations in mental status may be due to acidosis or hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/14,18,21\">",
"     14,18,21",
"    </a>",
"    ], although the latter is uncommon without concurrent use of a hypoglycemic agent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27562396\">",
"    <span class=\"h2\">",
"     Studies to obtain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory evaluation of any acutely poisoned patient should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status; this is particularly important in patients in whom",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      toxicity is suspected, and in diabetics generally",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Electrocardiogram, to rule out conduction system poisoning by coingestants that affect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific laboratory testing in cases of known or suspected",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    toxicity should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arterial blood gas, for accurate determination of the patient's acid-base status",
"     </li>",
"     <li>",
"      Basic chemistries, to determine the bicarbonate concentration and to assess renal function",
"     </li>",
"     <li>",
"      Serum lactate level, to confirm that any metabolic acidosis is in fact a lactic acidosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27562403\">",
"    <span class=\"h2\">",
"     Metformin concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obtaining a serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    concentration is unhelpful in most cases because few hospitals perform the test and thus timely results are rarely available and because the serum concentration often does not correlate with the severity of the poisoning or patient outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/11,20,22\">",
"     11,20,22",
"    </a>",
"    ]. An undetectable concentration excludes metformin as the cause of lactic acidosis in most cases. Nevertheless, it is important to consider other causes of lactic acidosis (eg, sepsis, bowel ischemia) in patients who take metformin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF OVERDOSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following treatment recommendations are based upon our clinical experience and the limited available evidence. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef68482 \" href=\"UTD.htm?21/32/22028\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Airway, breathing, circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Victims of acute or chronic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    toxicity rarely require endotracheal intubation. It is important to note that hyperpnea and tachypnea may reflect compensation for a metabolic acidosis and may not represent impending respiratory failure. If intubation is required, the clinician should pay special attention to ventilator management. Minute ventilation sufficient to compensate for any underlying acidosis should be maintained and arterial blood gas results checked frequently until the patient is stabilized.",
"   </p>",
"   <p>",
"    Hypotension should initially be treated with intravenous fluids, followed by vasopressors if needed. Persistent hypotension suggests profound toxicity, and in such cases hemodialysis should be considered. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Hemodialysis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gastrointestinal decontamination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal (GI) decontamination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    (AC) is suggested in patients with acute",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    ingestion, unless specific contraindications (such as bowel obstruction or GI perforation) exist. Patients with toxicity from chronic use are unlikely to benefit from GI decontamination. The clinician must assess aspiration risk, including mental status and ability to protect the airway, in all patients before any attempts to administer AC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=see_link&amp;anchor=H18993761#H18993761\">",
"     \"Gastrointestinal decontamination of poisoned adults\", section on 'Activated charcoal'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dextrose",
"    </span>",
"    &nbsp;&mdash;&nbsp;If hypoglycemia is present, it should be treated with 0.5 to 1",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    IV dextrose, followed by a meal if food is not contraindicated.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    alone should not cause hypoglycemia; other causes should be sought. The acute management of hypoglycemia in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link\">",
"     \"Approach to hypoglycemia in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sodium bicarbonate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    -induced lactic acidosis is controversial. If severe metabolic acidosis is present, sodium bicarbonate may be administered, but there are theoretical disadvantages to its use [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/21\">",
"     21",
"    </a>",
"    ]. These disadvantages include leftward shift of the hemoglobin dissociation curve, excess sodium load, rebound metabolic alkalosis, disturbances in serum potassium and calcium, decreased myocardial contractility, increased carbon dioxide production, and reflex vasodilation after bolus injection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=see_link\">",
"     \"Bicarbonate therapy in lactic acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Extrapolating from other clinical scenarios, we suggest limiting the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    to patients with severe metabolic acidosis (arterial pH below 7.10 to 7.15), with the aim being to maintain the pH above 7.15, until the acute toxicity resolves.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hemodialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemodialysis has been used successfully in patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    -associated lactic acidosis due to chronic use or acute overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/21,23\">",
"     21,23",
"    </a>",
"    ]. We suggest hemodialysis be used in patients who are critically ill, who have a severe metabolic acidosis (pH &lt;7.1), who fail to improve with supportive care, or in whom renal insufficiency is present. Hemodialysis should be performed using bicarbonate buffer, as the benefits of hemodialysis lie in correcting the metabolic acidosis much more so than in removing metformin. Treatment may need to be repeated should metabolic derangements recur.",
"   </p>",
"   <p>",
"    Continuous venovenous hemofiltration (CVVH) has been performed in patients with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    overdose [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/21,24\">",
"     21,24",
"    </a>",
"    ]. The clearance of drug by CVVH was less than that generally reported to occur with conventional hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Therefore, CVVH should only be considered in patients who are too hemodynamically unstable to tolerate hemodialysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antidote",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no antidotes for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DISPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of lactic acidosis may take several hours, so patients reporting an acute ingestion should be observed for at least six to eight hours [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients who are well appearing and who have a normal acid-base status after six to eight hours may be discharged or transferred to the care of a psychiatrist.",
"   </p>",
"   <p>",
"    If a patient deteriorates despite appropriate supportive care, the clinician should promptly consult nephrology regarding the possibility of hemodialysis. During this consultation, the clinician should convey to the nephrologist both the patient's clinical condition and, if available, serial acid-base determinations to help document the patient's deterioration.",
"   </p>",
"   <p>",
"    Patients may present with a mild lactate elevation or mildly increased anion gap, but have normal vital signs and an unremarkable physical examination. Such patients may be discharged home with careful instructions to stop taking their",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    and to see their primary clinician within the next several days IF the laboratory abnormalities are minor and resolve on repeat evaluation after a brief period (approximately six hours) of uneventful observation. Asymptomatic patients with persistent abnormalities (metabolic acidosis; elevated lactate) and symptomatic patients should be observed using the same guidelines described for acute ingestions, or they should be admitted to the hospital for observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of pediatric patients with Type II diabetes is increasing, likely as a result of the pediatric obesity epidemic.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     Metformin",
"    </a>",
"    is the only drug approved for the treatment of Type II diabetes in this population. It is logical to treat pediatric metformin toxicity in the same manner as one would treat adults, and anecdotal success supports such therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21799/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary table to facilitate emergent management of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    intoxication is provided (",
"    <a class=\"graphic graphic_table graphicRef68482 \" href=\"UTD.htm?21/32/22028\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biguanides are antihyperglycemic agents, not hypoglycemic agents; they promote euglycemia but taken alone are unlikely to cause hypoglycemia.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       Metformin",
"      </a>",
"      absorption occurs primarily in the intestine, and the drug is excreted unmetabolized from the kidneys. It may accumulate in renal failure. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pharmacology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Kinetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lactic acidosis is the major toxicity of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      and is associated with high mortality. Metformin-associated lactic acidosis may occur in patients with renal insufficiency, liver disease, hemodynamic instability, or others in whom high levels of the drug accumulate. In such patients, mortality correlates with the severity of the underlying medical conditions and appears to be increased in the setting of liver dysfunction. Lactic acidosis may also occur in acute metformin overdose. Among these patients, death correlates with high plasma lactate and low serum pH. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the setting of acute overdose, clinicians should seek information about dose, coingestants (although such information is frequently unreliable), and whether other diabetic agents are used. Patients may complain of nausea and abdominal pain; physical examination findings may include tachycardia, hypotension, and tachypnea in patients with severe lactic acidosis. Alterations in mental status may be due to acidosis or hypoglycemia, although the latter is uncommon without concurrent use of a hypoglycemic agent. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'History and physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine laboratory evaluation of any acutely poisoned patient should include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fingerstick glucose",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate levels",
"     </li>",
"     <li>",
"      Electrocardiogram, to rule out conduction system poisoning by coingestants that affect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=see_link\">",
"       \"General approach to drug poisoning in adults\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific laboratory testing in cases of known or suspected",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      toxicity should include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Arterial blood gas for determination of acid-base status",
"     </li>",
"     <li>",
"      Basic chemistry to determine the bicarbonate and to assess renal function",
"     </li>",
"     <li>",
"      Serum lactate level to confirm the metabolic acidosis is in fact a lactic acidosis (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory evaluation'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Victims of acute or chronic",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      toxicity rarely require endotracheal intubation. Hyperpnea and tachypnea may reflect compensation for a metabolic acidosis and may not represent impending respiratory failure. If intubation is required, the clinician should pay special attention to ventilator management. Minute ventilation sufficient to compensate for any underlying acidosis should be maintained and arterial blood gas results checked frequently until the patient is stabilized. Persistent hypotension suggests profound toxicity. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Airway, breathing, circulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest gastrointestinal (GI) decontamination with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/52/39750?source=see_link\">",
"       activated charcoal",
"      </a>",
"      (AC) be performed in patients with",
"      <strong>",
"       acute",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      ingestion unless specific contraindications exist (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We recommend that patients with toxicity from",
"      <strong>",
"       chronic",
"      </strong>",
"      use",
"      <strong>",
"       not",
"      </strong>",
"      be treated with GI decontamination (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). The clinician must assess aspiration risk before any attempts to administer AC. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Gastrointestinal decontamination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypoglycemia should be treated with dextrose 0.5 to 1",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      IV, followed by a meal if food is not contraindicated. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dextrose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      in",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      -induced lactic acidosis is controversial. We suggest administering sodium bicarbonate to patients with severe metabolic acidemia (arterial pH below 7.10 to 7.15) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A reasonable goal is to maintain the pH above 7.15 until the acute toxicity resolves. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Sodium bicarbonate'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=see_link\">",
"       \"Bicarbonate therapy in lactic acidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hemodialysis has been used successfully in patients with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      -associated lactic acidosis due to chronic use or acute overdose. We suggest hemodialysis be used in patients who are critically ill, who have a severe metabolic acidosis (pH &lt;7.1), who fail to improve with supportive care, or in whom renal insufficiency is present (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Hemodialysis should be performed using bicarbonate buffer. There are no antidotes for metformin toxicity. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Hemodialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients reporting an acute ingestion should be observed for at least six to eight hours. Patients who are well appearing and who have a normal acid-base status after six to eight hours may be discharged or transferred to the care of a psychiatrist. If a patient deteriorates during a period of observation, the clinician should promptly consult nephrology regarding the possibility of hemodialysis. Serial acid-base determinations help document the patient's deterioration. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Disposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       Metformin",
"      </a>",
"      is approved for the treatment of Type II diabetes in children. We suggest children with metformin overdose be treated in the same manner as adults. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Pediatric considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/1\">",
"      Service FJ. Hypoglycemic disorders. N Engl J Med 1995; 332:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/2\">",
"      Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/3\">",
"      Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Ann Emerg Med 2001; 38:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/4\">",
"      Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995; 49:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/5\">",
"      Bailey CJ, Turner RC. Metformin. N Engl J Med 1996; 334:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/6\">",
"      Howlett HC, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 1999; 20:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/7\">",
"      Graham GG, Punt J, Arora M, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011; 50:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/8\">",
"      Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 1992; 105:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/9\">",
"      Sirtori CR, Pasik C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res 1994; 30:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/10\">",
"      Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2006; :CD002967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/11\">",
"      Lalau JD, Race JM. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999; 20:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/12\">",
"      Seidowsky A, Nseir S, Houdret N, Fourrier F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 2009; 37:2191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/13\">",
"      Chang CT, Chen YC, Fang JT, Huang CC. Metformin-associated lactic acidosis: case reports and literature review. J Nephrol 2002; 15:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/14\">",
"      Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med 1992; 152:2333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/15\">",
"      Khan IH, Catto GR, MacLeod AM. Severe lactic acidosis in patient receiving continuous ambulatory peritoneal dialysis. BMJ 1993; 307:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/16\">",
"      Chang CT, Chen YC, Fang JT, Huang CC. High anion gap metabolic acidosis in suicide: don't forget metformin intoxication--two patients' experiences. Ren Fail 2002; 24:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/17\">",
"      Pearlman BL, Fenves AZ, Emmett M. Metformin-associated lactic acidosis. Am J Med 1996; 101:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/18\">",
"      Heaney D, Majid A, Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant 1997; 12:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/19\">",
"      Lalau JD, Mourlhon C, Bergeret A, Lacroix C. Consequences of metformin intoxication. Diabetes Care 1998; 21:2036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/20\">",
"      Dell'Aglio DM, Perino LJ, Kazzi Z, et al. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med 2009; 54:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/21\">",
"      Teale KF, Devine A, Stewart H, Harper NJ. The management of metformin overdose. Anaesthesia 1998; 53:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/22\">",
"      Lalau JD, Lacroix C, Compagnon P, et al. Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 1995; 18:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/23\">",
"      Lalau JD, Andrejak M, Morini&egrave;re P, et al. Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 1989; 27:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/24\">",
"      Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 2002; 40:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/25\">",
"      Harvey B, Hickman C, Hinson G, et al. Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. Pediatr Crit Care Med 2005; 6:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21799/abstract/26\">",
"      Lacher M, Hermanns-Clausen M, Haeffner K, et al. Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr 2005; 164:362.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 296 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-704953041C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21799=[""].join("\n");
var outline_f21_18_21799=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      KINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      HISTORY AND PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27562396\">",
"      Studies to obtain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27562403\">",
"      Metformin concentration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MANAGEMENT OF OVERDOSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Airway, breathing, circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gastrointestinal decontamination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dextrose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sodium bicarbonate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antidote",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/296\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/296|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/32/22028\" title=\"table 1\">",
"      Metformin toxicity - Rapid overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40646?source=related_link\">",
"      Bicarbonate therapy in lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/44/3781?source=related_link\">",
"      Causes of lactic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=related_link\">",
"      Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/26/38312?source=related_link\">",
"      Metformin in the treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_18_21800="Pemphigus vulgaris - oral";
var content_f21_18_21800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57924%7EDERM%2F77462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57924%7EDERM%2F77462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris - oral lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFFAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDR87GcH8RQbgDIrNlnBU84qnLcbRnNcLdj7NQubbXYA5PT3qjd6kqqQGFYk18QDk8VhalqYQHLDFKLctDCtKNJamjqerYz82K5q71cmT5Tk1n3Wo+YSM8HpVJ5EU7t3XvXbSodWeBicY5uyNQXUly2MfjWzpelmVwSpPuK5vTLlGuQua9R8OwRyRqRzmu/DxV7Hl1ZNj9Pha3UAda2rbVDbkfNT5bQBPpXO6krxE7fzrTF0rK6NcJU5nys7nT9fyTk49OetbEOvA8bh9M145FfSo3WrKatKuCDXl+25WewsEqiueyx68p6MPrUra6oXlhn615BFrMoXqTSLrU7yEDPFCxWtkN5Ykrs9fj8QKD97H41BfeIlHRua8tOqy4ySQKrz6jJLyCdv860dcyjgY3Om1zxCzswRsn2NYSavKXChvmbrz0rLRXLB2JLseFHYVeWAQoPlGWPJNc8puWp3woxgkrG9HqTrCDupV1RwcMcECsaIhieM9+aeow2TgseSf8ACodQuNCN9jZfV328McdgKRtWkYdccetZUfzc4zTnibbwQM9qxlNs3hQguhefUpSMFiPxp+oalK88ku6ItIAcRAqAcdMVQEYC4P8AKmqm8kKMAGpcmWqUb3sTf2jNkjJ4phu5nJJP0oEIHOAewpPLUZ7ZPWs7svlj2K0sjHO4nJqF0VwNwC55q00fHAyfXFR+W+MkZOaakw5exSaII2ADnsfWm+ZJEMhzkH1qxIshJIO3HcVWmiZmzzwODT5g5Tc0bWZkyGY8VvweIMDDyEsO2a4q3VgAT365FMcsshfJraNRqJzTw0Zy1R6Za+IAwA31sW+uhCCXyK8ht5HXaVatS3vJiCrHABGSckAU41n1Oepl8XsetQa4pwQ4wfetC31dWwd1eOQ60LeDyhGWmkbLyHkBR029weua0LfXzuBzwfer9ucc8sb2R7Jb6irAcjP1q6l2rehrymz18H+Pj61s2+vAn7361vCsmedVy+S6HoPnKTgHiopWHUVycOsqcfNn0q0urIT1/Wt4zTOZ4aUehsTsOc8+lZ0mWY4HBqP7ar8ZqxHhgM9BRJpjinAjVDu5GKbLCOdowTzWiijGAOOlV5wFY46etOKSD2l2YN5BhWGKxLuAjOOmO1dPcBSCM5NZl1GCGGOKmpBSO/D4hxOVnQr9Kg8wg4rXvIc59KyJ0wxGa8+pTcXofQ4bEqWjJEk9eamEmccmqCtjscfyqVGwev5VCZ6CaZYZyegH1pN3Sk3Z57Um3nNapjLSscDv71aWUH6VQU7cVOnTPrWsZGE0eczTADk4rMuZzyCafcyYBHrWXdTYJya5EruxnUq+zjchvbsJGTnkVxet6lhjhuM1tajOBG5LYOOK4PWZt8mA2ea9ChQtqz5vFYpzdi/Z3LTqeDmnyrNnAz9Kz/DpaXUIoQOHOK910f4eNd2UbsQGZQRxXowg5L3Typ1OV+8eSabFKk6Md2M16z4UvDHGingio5fCLWUzRTR4ce3WrMGnNbDgEd655VHSd2XFKotDqH1AMmOK57VZ1ct3FQTSSIOPTtWVPIzvzmsa2PdRcqPRwmESlzEmRntzSAZPA71EmcYNSBlU84rzpN9T6GCWxYUfL79qlt1BbCjjuajhAkweSoqwzKgwv6daukrasVV83uoUruLKRheg96UgK/I+VB1pscjMPu7R0561MsJk2qeFBzSnUWyFCj1ZJZIpDOS2ccVKULPlsipo41DKAMEdKtCIFyQMjrU8zasVZJ3KkYAbAGT6irUaHk9KsJAME45xyasxxAZ4GPepsDkU1h5JxyeOmKljtxkE8+lXRCrDOCe+aV1wNxB+lAKVyk8IA5GD1phyhAAHt71eK7xkDBz6VGLUlssx49qzlJ9DSLXUq7Ou7Io8gcAc474q5JD8oGMj3pscZ6FSAKkd9Cq4C4Wo9pJxtOK0JLcrgsMZ5qNgqoSASapaC0M14hz6VUuFwm4KSRxWyIcrxgfrVK6VFDCRTkdOeKZSKtohIyD1GSKZcwktuZTVy0UAEoxKgfhSXCh2IPBqvsit7xWjjwny8j+VWYI/MON5Tt/9ehUwQMEE1KqnHy9R+FQipIrCNgTtyVAwTgDJz1qJo/nJHWrqA5+cDHb0prJuJyKbJSsVUkdMhTipk1CaMHGahlh+fKHAFRyKUGWyfpUXK9mpbmpFrsqY3E8VoW2vknBPFcs6BkzioyrKeMD1qo1JLqZzwlOXQ9GtNZyF54rq9H1JJV2swz25rxq0u2Qj5jgdcVvWWrGMfeNbwrtPU8vE4DT3T2FLkBcZFVrm6VmwCDXBQa++zBkJH1q1HrAJGWHNdMa9zyngpROokbcTVabBFZ0OoqxXkGrIuEbgEV0xmmZODiyrdR5BPasS8TrkfjW9OwK+lZN4uctnI7UqkE0deHquLMSU7TTon5IzUV42xsE1SS4G88968yceVn0mHq86NqNgQOmalzVC3nBGP0q4hyOMVUWdJMDx0B9qkU9PXtUG7+dSR4ByDVoiR5PcyHOSelc5q90EyPbmty6JAJBrldaTcCx+tVhqTnK54uY11Bcpz97fFpGG7jNZZgW5lJJOPaotRbZKQGzVSO5dPunFes7R0PnXeWp1/hywjt72KZeoIIzX1b4J1G2utCjG5VkC4ZM8g+or5T8JLdahcxkAhQeoHWvf/CVrJBCmcjjFa0Zu7RzV48yOp1qFLiRSBkr3IrCubEYPAFdEqblyeveqF8uFPH4GqxEIyWpNCbTsji9QtQN3GPasN7fkjFdTqjBScVhTyqAeleM4xi2z6XB8zSM9kCn09qqXEZaUD161beQMSRTLcgvvbIwcdORXKnzyPaqR5YJFyBRBCFHLUluhaVlzkDk1JFCzLGhb5zyT7VetrfYo6En1olLoVTppK7I0t+gHrV6OLgseBTo0UAZ55/OrDRZGMcE8c1k2aNEVsM8gEVft4DjleaZDHtAUY5681pRHanXB7Yq4IxqeRHHFwAMnsfenGF24Xgd+Ktqq7cj60/eBwoHNW43MbvoQpFgDoR6U7bnHHB9qe3zYKnAFSRqGBJBBPc0mrB5lVoSRgcZpiQsJCpIJx+NaQUduCO1Oj2o4cqJMEHaeM+1ZNFc7SKXl469CetNMYUlh94+1Xb0Il1M0QCRFztXdnA9M1XXEkmT9wc0Xs7FRvJXK0gaRG3ZBBxzVYQ4BAXOa19m7r36mkFuMZOSaHdsfNymYsR2nuetZt1amQkElsmujaAEHaMGqxg+Y8YquW+gRnrcyLS18uLgZzxioHtiZX2gZz3roobZcHjk9cVSSIsH3DgE1bgkkEal2yksOY8Him+Uy+lWxEwkUj7vvRLF82QPrWTdjRMpyR4OcYIpuBg4PBq3LgJtP4YqBVKgnqalsuKuiB4hIgPr2quYmJwa0o8FTgZqN8MdowKegk2jMKFWpkicDuKuzRFckY5qrKQq8rk0nZFpcxW8nHQ9aQF4x1qyMMvy9ahuELMNvbuKSE1fRiLduD3FTJqEgOc496qmL5TkENUPJIDDFXFmU6SZ0Npq5TG9sDtg1qQayuAN3T3riG3AZU9arm7eNiCcVvGo4nDUwsZHp0Wqo/GRTZ75WQnIrzNNYeMj5j6Vaj1vdxv4rZYg5Hg7PQ1dZvQpODzWRFf7pPvZNZuq3ZkyVNZlnM/mEmueb5zspTdBpM9AsbncBzW1by5AHFcXptwcDPH9a6OznyFHPNZxdnZnrQmpxujbVjnAxUinofxNVYXJxzirYxgV0IiR4nqWpwW6NvYA/WuN1jXI5FKxFawdb1GS4uGUMcd6yQxzXo4eapK3U+NxcvbTuSXEhkcsaW1gaeZUUdTUZBJrrfCuhyzDzmQ4yMVdnOTZzOSij0n4baVHFDHuAAFezWECpGoTHOK8r8Kb7Z0RgV7V6npc6mFcHrW9DbU5q3kaJX5DxWHqjhAxJrYnnVUJyAPXNcV4j1NVDhW5oxVRQiXg6LqTsjC1u9y5VT+NYE0jMMg/TNFzOZZSc96YDkjOa+eqVLn2uGockLD7csQC3U1fgj3nAOATmoLeMk55CitGFdrADH41ldnfTp3LkEYL5PJq8VAA4/Oq8AA24+tTO24jb+tO5fs9R9qMv83StIIu0HiqVnHgjqD3q68gVSDxiiPmZVIu9kKkYJ3HgVJFy+DgDtVQyllAyKlkmVNu089T71aaQeyfU0x0Gc8VYjVWUnjPXPpVKF3ePdt98VPZSbpNvOCatSRzypPctC36c1KUbYMDmpVjxhh0qRSXJ2ruAHPbFDZg9TNdvnOQc9Kli+YDFWmQYPyD3z2qIRBGGDwaztdmikrFWZGL8YK98VLBEgQgjGepqWcrKFiUjEZPzgYyM0LGyITuyOuaGkncptuNtiOMBG2k8DkUSPkZXnHcmq5LNLkenTFSbdn3uAetCaewOFndktuBKrZ5B6EUCNTIR1PvViAKq5FICueB8x69q0iu5hLVsWS3COwDq+P4lORWa6KoYEEDrnFa6oFjxjHFV5Yt69voa1lsRB2KE0Som0EnjjjrUJj+Xng4q1JEVOcjPQVH5eEJbB+lc8joiZpiV5c4yR1pXReTjkVJIx8xQMYJ5FI7FnwqZxWbVjoSbsR+Wu35DyT1FRNb/ADjOPwqeOPdkj8s05gyHn9KLCej0KcqDJyM1RuEQt0BrUYAqxGOR3qqIVCjP50mXDTUz1h+c9lBzimyfO5GMADsKvyoq89jVW4AUbunalsWtSFk44FV3UHoOlWFYj5T3psgA3YHPWqTIcbGdIFXOc89azrpRyMcmtG5VgxOKz7hioBxz0qubQTpXMq6RgSRj8aosXHKnBzWtJ84PHPU1SmQoSxUEYximmc1SnYktz5kRz170scPzcA1WtnKSYbO010FjbbgD1zW+Gp887Hn4+dqdxLTKADv1rcsp8EZ//VWfJb7RkKc02Gba+GOP610YzDez1QsrxnN7rOvs5uASa0433CuasJwccitmCbgGuSEj3JK58eMdxJNIKSnKCTXoLc+HNvwxpbapqUcSjKgjdX0T4e8NpBpyfIAcYx6V538HtCPmefKnzMQeewr6FtLVfKwB0HQV7WHiuS7PMxM256HFTaSIX3oDT4r9rUcniuo1CBUU8dK4vVwGcqvT2rHEtU1zI1w/vuzFv/EJZCqvXMXl01zJ856+9W57QIpY5xWNL/r9oHevFxFSTtzH0WXUYttonnCxqAvLGkt0Ykk4xn5m/pUJIbk/hT1dnfbGeB6V59Setz6XD0W9Ebcawva8SRxy8uuX6qOxHY+lRwTxqQMjcetZn73cA3WrdnZzORIEwoPVjisJVHLZHqU6EYLVm3Bzz2qct0BPXqDUa5VAGGHxz7USEBQQcN69a1SMmrstQyEA9PwNJLKSnPboKhhBEJkLAAHAXuT/AIUSsvkkNnI6HFD2IUU2QNct5mAep71b07Mjl5Dkds1QhR5PnCnj1rXsVI+8AvtjpWcbyep0VElGyNeLnCqflPvWnZoASVUD15rIimAcKh7da045mCDGNvpW6Z5dWMraGmh6k9hgU5AFRlPBY54NU0nAPzZ9jUjXCE/Kc9gTVt3ON02iSb53AHTHNNiG0e3TmojI7MNi9epNKJArEE5FSVyMckaglsDGeMVJuygwPlpLiWGS0txCuJfm8xgevPHHbiq3nFSFz06g0NWBJy1HlVjk3EAE/rTiQ6nGDntVGeY/eyafDMR/Smi3TdrlpGwOR06GnjayK65znoapmUZxjk08znjb1B6GqUrGXs2y7I+T36VHGynjJ56knOKqyTsAT+lRfafLVmxyexrS+glRbLM+5GK5Dn2qrK3ykleR2NEUoaIvtwCeTUbOrSEbmJxWbsbQhZlebewGFAB53A050DKSo2FevPWnTSrkIAcHpx0pq48zrzWbZ1KOhNGgKEYI455qvP8Ad3Et7VIJSMqH6n06UsjRk8Y3DsaERyNO5SaQIoXAyfeoVJVgpwQetXZUSVV2dfSoXt+VC0ne5okupUulO392vFZpkLFlYE+hrbIGwqPvelULi2CAE4NQ1qVBrZldBgggZU1XuCQ/oDV4hVQDI9etVr5Mcrk5p7IVtSjOM5Ws24QsrAZ4rSlGQSc5qB12tk96bVx2sYrRsh3VHLHlThSK17qAFc8ZNZ8qYBHXuKVnEzlFSRltGAfRhXR6FMGUK55A/Osa4jJGRS2lwYSCe3SurDVlCabPJx2Hc4WR194F8rIx0rlbq6EcpGehq9/aPnxEA9u9Y91bmSTcM4NelicTCrGyPBo0amHldm/pd7kKc10drcZArirKIpjqK3bWcqAO1eRrF3PqsNXVWCufM4GSK6rwl4ekvp1kkX5R0FZ+k6S9wVkP3Qelep+DEWJ1UgD1r240nF6nxE6i2R3fg3TBYwqqjpXotpJiPnp2rB0W13QjA+uO9bixeWh6ivRpJxVjgqtNlHVpvlOOhrkLwAuzEiuh1eYIjHNcLq2pqCVjOTXNjJxiveOvB0pTdkVNZvAikKfy71hjcVO7ucmpH3XFwWY5UdqmCAgf3f5187Wq87ufbYLC+zjZDVBZcAZY8AVo2dt8myPDP3I7VDBEgIJPXgVrW8kFpFsCmRj3A4rnSu9T24LlVo7jbW1InChNxzgtW7HBDD/rXUNjGD61lW0jo/mnLH+EY4FTNbvK32ic4KgBRnqTW0WorRDqXlu7D53AcYIJA5IqBVVlzuPmE/dA7epNTQW73M6RRlFkc8bjgevWpIN5keaY+ZIHyQRwwo5W9Sea2gqw7EXeTjHApnliXkipX3u5G3Cgmprcbc7h9DSkr6EqVtRqxBYx8ufpU0YbAU56VKqcDIHHSprdB5mHJCk4JFCiw5yNEJQKBg9zWjFIAgyahkQKSEzgHAqt5gQfvCRQ4uJPxo1id6gg5ApiuyHaD71T+2RFQEbBxjrSNNhx6GlfsSqb2ZoG9AUgAA1WactKducd+aqs26THIx3xT2+XJUnB4NK9xqkkXLe4IzzkDtSTOxcsTx1qtA0aSruzkflVp2V8kEAVa0RMoWYxnycA9qnhwE4xntVJZAZMKMr0qwj7SPQ000ROD2HOjY+WnxIwyATz3prS5wBjB70+CRAwUr83Y0mZtOwt3Huj+UkH1qCRcgZFWhllfPTFUpCcc/TFD0CnfYjaXaNmcio1mDSH25NQTjnliD9O1MVgq4ySals6o00kWJptx5BqJZgM5bmmTnaMk5wM5FZj3K5+VjjPQ1jKVjpp0uZWRsCRmJYcnPpR5pUZyCaz4LwcgmnyXGDwM0c2lwdJ3tYtxSkDIOGz2qxlnK5bkfnisdLkByAeT2q3HMxUdwKaqJkVKLRfUBQD1xnn1pJ40BBAG3HWolYFe4Oc0gzgru4NaJqxyyhZlf7MATnHPSqk7bcggnHFXt+0kMPm9ap3BBYjse/vRZWGk29TNf5gfQ9KrXEZCDaeRzWjlNrb8gkYHpVeQrt7fWktjW2pViBZSDgnvVe5j6gDirqqFBO4D+dROpOcAHNaJXRk9zEmTBIx+dU5VHPFa91Fgk+1UJlwMCs1ozKpBNFG2ysvHANdBbxb0BxzWIFbzB9a6jRlEsagAZ962prmlY8XHx5YXRD5OOcUmSh5/Kt17UEe/rWfdQFQeMCvSlgvcueRhca4TsfP2law9oVVuVr0Dw/qfmssqDp7V5QvB5r2L4caVDe2yktjODj14rphOUtDhnFbnq/hXXUMCiRxx61v32v2scRYyAj2rjI9Aa25iOBjOM1Q1SwdYSryZyPWu2PPy6nNKEGyl4p8X+dKYbckk8Vi2weX55e9RSWMYud2Nzdq0QojjHrXhYyo27yZ9BltLmkopCIoHy8bR+pqwsY4J6VEiGRxgcCtKCJAP3i5Uck5ry7ts+wpU+UhjfDhVxtGSx/wpygnLL07GtSCwErtIUCpj5Qaux6V5YBcgJ6UlCc9jpVWECHTbdnjLuOFXg+9PePzCDggqMEk9a0nlghCoR+7xjA7HsfpWe0gPmbCCN2QR0rr9mo2icvtHNtkCOYJtyHGAVyVzgEVdQKwHBHGQBxVQxmSRUXLMxq0WCbePm6VUAn+IyWTkKcAZ4p6jBG4+3SkCKzgkZNSAZJOKHG4K1iZfm4BNWImBODiqjFs4Ap6F0xx+NCVh8ty6T8wwOR6VR1IExM4bdx2HFTI5P36cIxt2cFT1pS95WKh7juYMQfy1U9uOK1o2DQKJB8wHHNONmiHcGyfTFM27pSuR1xXKoOB0ymqmwO7ALtY56Yx3qzEW3BT1x1pIrfDDcc85q4FHmBjggU4p3MpzWxXMDsSSMN1Bq0FL/LjGBS5yxy4Cjpk8/lTkY89QPWtVHoc8ptkSqqEgDlf4qlaIHBPIqMlVIz65FTq6hQF/nVKJDb3G+WcggcDtSgBRuxyOtBchhk89BRhjj0+nWk0kTqS5YKzKM5HSqVwr43NgHPrWjHhgQMjjvVKcEBuBj9aTdxU9zOb5jyOB3qKcMrcZIPFTsysQp4OOlMkO7jpilJHXG6IGXMZyeO/tVPVYYW2kYRyBgr3+tX53aK1kKJ5jDt61lXTmaEO/wApFZzSSszoo3buivCgjBLPg+nrTrpz5YIPB64pkrABCCM9RUDO7kr/AA1ztpKx2xi3qIxbduzgetaNjcZBRiSaqwx74tvBxVq0sZFYknJ9KmMJX0Co48tma9uWDKT1q55S43H731qnEGTGegq3zIjdAvoK6kn1PJq7iSwAjzAOo5wKznUAFXXrWoCwiIIyAODVWZQVJCjB7d6uxjFvqZMkWGznIFVZIyRwM/0rQuMKnuarMCucpnIx9PelZs2VymhC+nB5Bp84H7zAAK9APT2qOfjJALY5yak3GSUSI2HUA8ZOfr61pTdtCakepRnTeM44rMuUIzn8q252VyzHGWOcDoPpWbcrznvSmkQldGVLHg4yDjkkVuaBcKrgZyvasWfKnKqSnepLOXypQy/dNKnPllc4sVQ54tHpUKLIoPUVSvrb5T0qLRNQRkUFuPWta5ZGiJ4+ua+mozVSmfEV6UqVSzPmAWdrdgbY9ma7LwZ5+kvmNz5fHFZraLJDIfIYMOwIrqNCtmdfLmTDV5iqqMlys75YednzRO2j8Sh4cMOcYrH1HUpLoEJ096fHpqqOp4Oar3flRCumviKihq9DloYfnnaK1KaBVO+Q89hSgmVtzcDPT0qEmSVs8Y7c1NAjb8upIr52tW535H3eX4BUIa7mrp0Ks2SCFHc1tWsCTv5SIDwCw/lWXbSM5UKAqD17VdtZJIblnjDgnGOB83vUqorWOupFr1OhaOKOAKxBLDnmqN7dBsRrnCj6ZoDSC2aW4+VzkjI6CqLSCX95u684rdS7aHPTpa6iycrljkA4AzTFYsrbvXmmuwZf61SvbtbZVjLAufmIpe07nUqZdB3SEg/KKtQ4JJbv2rFiuyEGT16VOl7gAd/rWsKkUjOVJtm4iYkDDG0dB6U0urMdnQdaprO5QF84xRFMC3PAqnUT2JUH1LxJHTrUrPtAyBTY3Uody/KBxTExcMVyAT0FXewJdyzDskOMjPcA1IdqjAznFR2Fl9myxOTjrTpmw3rUO/LdhdOVkISfLJ4pIkxg4wSe1SxhcZI609EAyx/WsXEtSsDOFQnn3qJpCeh4NTMm5Cp/SkaMuFOPlFHK7jVtxltli24fjiri/d25zTREyR5XgHrTUOwgNzWiVtzKbUnoDISwHaiUlTwMClMoJ7VJIhRd33vpVcvYi/cYp5AHWplcjIb04qjI/wAwK5xn8qnVt8e48844qEruxcoaF+FskE46VBdBTxj8RTopdgVWUFcemDVeeRgMZBA4xTcbIwUfeKUsab9w64xUMjAkhcEjnnvUxIZc4PoTVeRcksvQfrUM615kNzMDAyrnPfHasYNJMGi6nrzWwybmO4VUljCYO3IXg+uDWVSLep1UZKOhmyKyABqYSQuelWbh1djsyQvQEcioHQgD5Tz61ztWO2LuWrIAANkHPXiteBX88YOVx0xWPpS7nxzgHv2rcLNGV7ZFdNFaXOWu9bEvViME4PSpUfZJgnCtxxUe7LKwOPwp4kVyoJ5HJq2cMlcsy/Kg2kEnOKpTZOCcYFS3Eo6KRnsapySHaQw5PHNLmsZwiVLhd7gYyBzUN1O0cwUYdDgY7g1YZgqOuckjgiqBTY4ZV79T3p37G6S6kVynJZfu46VXSVlUYJwvIxV2RSshUnI9qgeEbT0+vpQ073Qna1it5nPJqvMAW7c1O647dOOKrsBxmk5E8pUZPnI6cVWmXaox29K0doaXB71Wv4tyjbwVqNlczqRuR2d5NCylQxBO0YHU+lad9rpjjKxs/A+beMEN3GKpuqXNvZot5FbGBdrRyMVw2c7hjrn8+Kpa3PFcXxaOTzAqKjSHjewHLYrpp15wWjPIr4WNV+8tR3lO7jAQEmn2w+zXrK0pYjoV+7WlLABnauCOQarSBWOQmGPUiuZycT0/q8ZaMuS6i6oCoWs8RSXEgL9WPGe1WIo1aRQwyvQCtFbYohYqMkYUUp1Z1d3oVRwlKg7xjqyslmIxtYhjUgiL/u1QbjUgMsYOU3L6n1q7pThZlkkUEyHHI4FZSV3Y7Ytxi5DYrN4Ym8w4XbgYHU1s6baiL95I29sYJ/wqIzJNeMFIZIx17A1IJwZVjUgKa1pxgmcsnOerJJzvLluR0Ax0rGkjYEgqQfath8AEnp71javqcdp8irvlYHg9vQ101IpLmYUm72iUbu7W0yCd0mMhB/M1iMzzSl3yZGOSTQS0jtJIxYscn3qZOSAAdx71wydzuWhYt5Gi6gMcbR3xWzZ28KRByAZDzkjpUVjYpGgeblz29KscOxUA4H610U6bSvIwqVFtECTI3fA9anjiA+bJyOM0Kex6VJnIxitLIxTYP5irwc+gp9pnueaXyyQM9Camto1VsHmlZ3NOZJFhGb1PBqUMMEsuT60zIBwAOaGJUnp+FaN6GaV2C5xU1tKXyCMYqNE3Lknn6dKfGPLOS3UY+tQtymlYkUgydenerIbBAxx6VUVcurY5zyKsS4Knk7h3rWOqJZM1yVjC7QQT0PWqdxIsjny1ZSB3waViCQpPJIGKbcpiRQox9Kt6omMeVjIyDKgkPAPNS3N4W+WM/IOcY61Dt2hjI2OPTpUTARsNxBH0os0i7JsswEMSHx17danRU3AKRwcgVDFBIYw6LkelZ4laO97gdOappRSuhqPPezN65UmMSAcd/aqE27bgtwexp4uwRt3HntnihQJJRuJCdc4pyipbGMU4bldYx5e0nn2NJ5X+RVqaNfOd0BCnpTVIA5rL2ZTn2KUikNwBTfKDxkkKD3Bq6wDA46Gq067AMt1PaocbFxlcqi0RnztGcVW1QRLGy45AzWqhB5AwMc+5qjqj/uWAGM9xSlBcjOilUfMrmZprbeQOa2piJI0I6iqGmwhY/Ue9WwmQNvQe9RSTUS60k5XJdwEbNjtQjqOSOfpUa8DbwT14pLnKMp7NRIxSu7EbM/ngsAVzUlwymMnpk8YpZRtgHUk1GfujdUx03E2mIdnlZccHvUJf5HQAexNR3BKqVbP0qtGWzjJ/Gm5W0Fytq9xyxhsrnD9vcVExPzAqR25qxJG0kZUDDdsVEu5wVmXa68ZPeqsxXKbDbz61FJHn+dXngOCQQc1XdMfLU8rBtMot8rbh2qwEWeLdH360u0ZdSOo5p+lyLbzEtGJVznYTxUx0dgkvduXDaXi2VqbA26KUO8Ns3Fsnk5/CuU162uBfl7llMwUfcxgj8OK7G4vbdk3HTrb16n/GsPUkjndmSJIlI4Veg/OrnFLY44xbbujUNrIQGxsRm2hiOM1lTRbXYDmtpncxbfMO0Hdjtn1rNkjKE5Uksayq7aHdTvfUgjjbIbpjpWvpu2dREww/rVFVwvT5QM/SrenfNN8o5rOl8ViqqvFs3DppfT3XcjoT+KmsNkNrP5eN7KOB2rpIJGgjGMP65HNVr8iWczeUqAn5sCuqvRTSaOLD1pJuL2M6JvJtnKgBT79az3uAkokLbsHkVYuLwRS4VQUB6GsrUZjcvu2qpPOBXJOy6nqUoPqi7LrG1G25Z8fL6A1i7WkkLOSzMeT60pXOMetTwlI8EkcGjnc9JMUoqn8I/wCy7IS2AangtwQr/Nn26VLA6XEgUHKjrV2R0VdoP4V0xppq5zSqS2FRjJ6hRTzhCdnU9areYzdOKfHuzmqbISJ4FOORz9auKmcY4JFU42bdkYHpV6PgbsU42FJ2J40zGFfJIp8ahRnvSqCRlePrTzE0ah5FIV+hPetErEc1xCpblSB9aHBwATyKWM5U46epoY4K5NZyVy02tByqVAB/WiRGdlH8P61Kqg9eaedvXBwapQ0FzWZGGOcZPHpT/MKhgR+Bqvzv5JxU+VJxmrj2Gyu2/fnkAelTxNlldug65pszKqZ53dRVCW9GwhSVNXpDVjSc9i7cTRrlmYKGPQnmsqaV7jUAsSNtIByOlUZb/wCb93Gpc/xPyaqSXt3vO6UgHnC/KK5KuKWyO2nhmjqP7VW3SSKZchRj5T0NZl5ciSQSI3B/lWJcTM4xnAPenxzHysHGcYqKmLc1boaQwqhr1NO3uGlutpOAvI5611ViFdVGfzrhrTd9oG5sE9DXVaTO4CgkMcZ4rfB1buzMMZT00NG7dFbaOW9Kpkjac9TVpold2bjcfSmSxKBjrgV3Si3qedGyK4IHPTFV7iQ9/wA6mkJYYANEVssso89ysZ/iAziuaafQ1jaOrK8XMnUEEVXvVzww4/SraxCNM56nA96q3A3NjtWbVo2ZtB3ldCRqsa8cZFWN2xAOPwquEII3cVJId/IxgdKUXZWHLVjkORgcCpcK64bHy9qrlsRAryaT5yhwp3f0pN2Icb6kkq7+/SkCnbyPpSEbVAI+ank7lwDSJba0KdwmMZGTmq6f6znmrDH5iGGQPWoyBuBGfpU27FJ6WHNyeP0qu+AxY8mpwPUe1V5lAb261o9jNbjkIVS8YJ9VqKRVlXzEHB7elCOUYFCPepGcMhCjb3+tWndCej0Kk0WQHWqLHZLlSAa0irbRjkdxVSa3EhwBgg1jUj1RrTl3GkPLhY1YsTgYGcmi48sbUEcqSDh/Mx178YrQgvI4rJSHkEsUJiCBD8jMeXyPaqOrSLPOGRnkCqse5hguQOTWTlYEm3toaEag70bjI71Dckho1bGc8VpTW4PzcbjzVS+gbyVlAYqhwSB0z0FOSdghKN0VpoWj2smCCOlTaWxjui20FR1qq9xuXYpP1NTRlkTBGD1+oqINJ3NZRcouLN+S4jXDqcEVmXt4G27HwM9qyry6Y4SPOTxVf55IyGYjBzWlTEuWgUcEo6st3YBwGwc1nMRHKeOOnWrvVATt6dzVSQZc8LnPasJa6nTflViIlT0/XtTYkEkgH8Iq1tBQ8Dn9adbDDqNoGe1aRp7GEpllIREpZG5NKAzsP1qZ15GBU1r/AK0iunl6I5eZ2uRQxE84/Crccfbbj3p+CrnIAp4/OjksTdsNuMYH401HcMRx9M1KOfXOaVrcbcj64FDQJ20ZPExIzkjHpVyWWNoFQM4YdS5yD+HaqlsnGO9T4yfmBq4t2Jkk2NVT/eBPXNKoz1OfSnEZxtIyOMUxTtlBIwTWbRonckQEEg0uQOlPc5AwM800jr8tVsK9yGSUDnBPtTXY4DA8elKTjoBTmkPlEFQPenHVmiEkfegz6daxL6MsCu45zV6aYDhW69vSs24kZ22hs5PSs68k42OmhBpkIifyl3L06H1quo82UjHHNWyzo4QtgjkVULOHY85zXFJJHXG4skQQA9feiAKzY9fWnoGCgsNwqaJIyQc/hU2HzaagYMgZzgc5rTtL3ytkaZLkVUm+RBzkGoLd1+2IQcDODW8JcklYxkueOp1FvI5HJGe1Tli3OOlQjZHErD6VDHcfOY85Hp6V6jlbdnlcvM20WSNpHy5B5NQzTHOzHGOtTyyhE9utZhBLs24gtWNadlZF0o31ZOZTgLuGKileP73THWmKOeajlCk4Xp7muV1DoUEKzbjmlKsM88HtUG8qMDnFPVtwGQaIzG1YlAwAF4704Mw7c9qryMw69vSnQPlstninzGbXUsQxvKxAbBxTACvDA0/BPOcfSmABWyDknsa0WxA1/wB4Mj86QKAPl6+lPYHHA5PXFMAIJ6ke1C3M2uwx0w3PWqsiAttYjNWJcckn8Krzpuwc805PsC3IpFKLxg1XMrHgcH0qeblQOm3k+9Vg4ySeKjmsaRVyWNwAT39KY75IbH1NCr8gf7ooP+zyO1O7JSRsQIt1p5igljRfJKshcKd+7OTn271nalEsmoA+asm2NVZx/E4HJq4qlbS0aLT4rgMnzSeXuO7PTirN/BCbeYi2jhMezBQYwx6qfUijlTMoy5WNVsKQ3UetZ+rySC2VY92CQSo4BrVmVgSRiq8ybyuQCuOaqcLppFU5pSUihptskcPmS8ueSPSqeoyM0o2cA9xV69QjOx9u3t61Ul2SR78lTgY4rlqaLlR3Und8zKyr5abmY5z1qMv1J71LduG2rnCp+pqnLJyMA1zt62O2KuglkPCg8U1gyOBgnPenABlLMcvngUKC7nPA9a0gjCp2HiQnp0FWbVWdgxHSq8Ckkg1o2uIU2nJJ710U9Tkm7IsjBxnrTWSR5F8ptvvQGCuxYA5qeGVWPyiui6ZilYnjDKAHO4+tJMCrcYPelzsIOOaazqzbiMHoKbYRXUfGw6nipA/zbgTzxxVdw3YVNGBtznn0qGx2RagwBhePxqZjuAP6iqi/KmT1+tOSQkcYpJkW1LGQB15FCryC561Fnp0461NlWxtA4FIaJ4zjGasNskTcD8w4PaqwIYcGgyBVIPT0rVENN7DGUgnOMZ71BK2eMcYp0kuetRB9oyOnqaFubRTW5WEal9vf1pmoWyxQrJCoDdSc0+5YxnzODVSS7LNyBtz09azlypNM6YqTakiGNBcR52sZO2MUPAUIzG4bGecYqd54xIGiUICOlWoFjkCEPnuVbkCsFBPqauo1rYyYVMjEMxAUE59P8auWMKtl9oyehJ6U2VVZpBGjqWOfarlojF1YJjHXA4NKENQqTXKQX8Q2AHj3qjDAVY7uM810t1axvFmRgmOlYV9cKIRHEm4gnmnUp8r5mZ0arlGyLVi00rbUfKDjmrjp5EgbOSRzmodGlUxDA2t6Grs0SzSbiPm+tdlON43OepK07W0GHdMpKjjtUB+XjoauiPbHgVSmOO3zZqKnmFN62QjY5wT9aqO3luQ3IqxvyAOBjn61BMPNPH6Vzyszoh5gXAyPXvUiEAA5FJCgUDIJ5xT5o8jpUpMiUlsOd1YggUwYaQEEY9KYiEDJPtzS7sHiqS6kO3QnBxwppqnBO4DJpMkDHrSqNpJNWjMVySSR1pHAWEsH59KazDPcZpiNtcOV3Ac496pCcSMgquW6dqrytyT6dqsO7uxaTg57VUnbk9CaG7CSuMkOBkiq8jDZx061DczleD1qozmQEZP+NYTqLoddOk+pofavNTaoAA61PDG3k+2aybZWDqexrejViqqD7VdKTnqyK0VHY0rRIIbcAidnaEzHbKVHB6DHsKrX6wrKq24cRMiuu4k9R1PvVr91aQWplnuN2C6CMAhc8Ec1UnuEuLguhkbPGWwCcfTtW22hxRi27mlJG2xm3gnBJB4xWdvZcjgD09q0bxiR8uBuHWqLqAhLdK2q+RFF33M64mRpGUj5gMA1n3EpEnl9QOlOaK7vNRFvZxvLO5+RFGWP0FVr6zu7C8aDUYJLe4TBMci4I9K8qo27ux7FGME1G+pGxYTYJ60+BHmbA69MUM6KmcfMas6cGTL5wDWdNc0rHRUnyx0Fe3FtHukPzYqGJTMfTHarEzG4mO7BUVIGSKPCfU128q6bHBKT67kfEbBe+OaTzjnqMVTaXzZiBwD3NO2/MQGziolU7FRp33NKF9xGRxVpcg4XgVnWrHHB6etX4n9cVrCV1qTOFi2i7z8xoChJCB+dMD5wQcfWh2yeKttGSiywEBByf/r0+JA4K4/Go4hgckVPB8kh4Gcdae7IkiRCEGSm7/epTGzhpEUYHap5AGHB+tMF+kMGyLG7kGqaXUzV38JTzj71PRsDIHFVyxbLDPJ9KfBKArDd+BFZm9tC2kp2U1n3kqD1pEVJASpIPoaniRUJ8yMMD/nitErmd7Fe7VFVPLbdx34NQq2Ac9MVYuY1EmYwwXH8XJqFuFwRQ007msZJozrqQuCC2B71Xh2yPtYg/U4ou4HkY7CfeqLxOhIcHHrXHUlK+qO6nFWsizKCsmCAMdKI7gwsckgnvmoFyE9eKZjcc5571i5NPQ1UE9Ga1tckv8u4gDnOK0rK78suDjawxXMQyFGIWrkb42tg7TWkKrRlUoKSNjVJ/OCqre5qC0hRXJYZB7GqEtwCfp1q7bTo+AMGtoVFOXvGLpOnGyL0SKj71B6flVsYIHrVFXGM5wRUkcm44rsi0kcsot6k0hcDIOapu2SeetXJgc/LjpVeRR95hzWVW5VNpFYc96lVOetHygrtxkngVJ1asEipSHBcAd6JFBHKnrTGZg2e1ShjkZ6HvVJGbb3Iyuff2pjxgEkDFSzNgDA6+lMYjBJ602lYSbIznHtjJpQ3BzjFQ7/3nA6DFK43DHGalMqxKjAtkc024JO7I5PYVBGHRs4/OlklLHmqUrolx1K0rFHzuI9qp3MpAzt/Grsqgn1qjeRZGSTx2rOd7G1NIz5wXOQDTFUgbvyqdozjIaomUqOvWuZpnZFontpCDycD6Vr2UpfODgDisi1A2ljkn0NTx3awzI5USKOqE4zW1OpyasxqU3PY6+Lzls4EtpbZEwdwcrndnrzVC5jlW5IlZHfA5TGD+XFVLXV7R3IOnBfXDtVoTQyzFol8lcfdBz/OuqM4y1RwOnKDd1+RclUngn8KpTZBJ9BirzkH5cflVa7KrFjOB71vUWlzkoys7GfZ3NxpuoW99ZSeXdwPuRyAcf8A1qzvEGrXmvarPfalKstw2FyowAB0AFbU+k3raUdSjtpjYqdrTbcqDXLnIO7kD0xXmV3JLl6M9bC+ynL2is5LS/X0I2LunyqMDvVuPiFcsagjd2O3GBnmpm6/7IrKkjavU6C8k4HA71LFbSTOFXgUkfOMenWr1m7J8qLyTy2K7YQUnZnHKbSuiFdFmXnPHfFWYtLCxl24A7mtMXax/K5A45rG1nUnnAhgGIxycVrOlSpq5nTq1qkrEMwjQ7oTk55FSwSFhWVGrseAcVdgyOuTXLGV2drVkXkfBqUODwRj6VB5gC8dvepI3DKCRzWlyLaF+MjAp+earBunrUisWbbn8a0TMWOlkIHDGnwwxtG8rfMV/h9TVd+PvfpQWaIHGUOOc0763ZVtNBy3UpJCBVB7elJO2QDtAb1FZ8tw/O1gCv61JZT+czBj82OKyVVPQ29jZcxo2jfvFJJz6+la4g2Ft2CDyD7Vho+wnHNTi6crgk56VvCSRy1INvQ0LxoyPk7VnSHOMZ600vhiR3pkkuMEU5TuKEeXQXA3DnHPcUk8CyqeBUTSdOmKso4I4oTUtDXWOphXELQuVByD6VXZfl7g1uSoksmCMnPQVQv4QHVUHzHtXFUpWu0d1Kreye5UjXqQR+NOX/awT7VKZGh2oY48f3mFRbSX3YUH26Vg1Y2TFljOCfXmm2zmKXJ6VNKzMgAJ4qBnBUdzS2d0Naqxqi4JUsuCcVHBdOHZmJ3E1UsgRJkHg9q04ok37ytdMHKdmc01GN0aKy7owSenPSo5G+XnpTXdeg4Haq7sRXRN9DjjG5KxXI2nn1pFkK8dz3qsM8ZzVhRu/wAayW5Ukki0pBx2zTTxUTsQRUitkHPrirRm0NaTH3qYzE4GevWiYYU4xVcn/wDXQ2Cjccz+XnHJpiyFjz37VDnL5PanYwCwNY3bNlFWLQY4P8qicBjxUH2olQhUDBznvUodR83UdxVp3IlFxHOoQsp4INV503Djk1JLL5zbtuDTATzxg4qnqSrrUy5kcybccfyqOTEbbQBnvmtKSPAZjg8VmSuWlyFxisZx5TppyuK5AQdqjt2QzKZULR/xKDjI+tWHVWQjp6VTQZLDHSspmsNUzorK1jkVJrbTrh4m7+eMH8xVq6TypyogMJAHyltxrLtbtClqH80AxNbMQpIHOQR6nnpWlNMsswVWdtiKjMw2kkDkkV0UmtjjqKXNr+pYt5eMnrVbUJfM2qq5AOeuKaWVckkg9eK6TRNK0LUNLln1C/nsbiKNpQMKRIo/u5PJz2rts5KyPIlUVL33+BiDX9QTQpNI80pZSvvaIYOT9fTgVgzLlsnt1FPlkVsOh3ISSCRjiq87DIyTXn1W5Oz6HpUIxhflVr7kUjAdBimg549agdiznoBUi8dxkc1MEXUkX7TBIB4x/KtEy+WuEA+tYizDt1q7DIWI3HAFdNORi431HzEyAjkbjURVUAAwD1yetWpSHGQP/r1V2l2JPAFVKOppCWgwtg4wDSI/PT86DES3BpgU54rJpo2UkWY8Ecn61OoyMVWjB7inlyAMU7C5tS4km3juakWTA3ZrOSQ7jmrCPk8jihMTiXt+ec8Gorq5aTG49Bj61C0ny8YFQuxNXJ6BBa3Kbu/mcjirVk374BQfemqoduR0qaMLFnbwfWuaNN3udUqqtYuvtVuDk4pm7nqOKrLPzjP1qVWBNdSs9jlba3LG7PH6U1yuD6Y7VC8ntTS2fx7U2tDJS1BznpxU8LZQjiqZbtmnq+w7qzi7O5vfmRI4ZWBBxiqU8reaG7/WrE0jbcrzkVRcODubI5rKq+x0UtdwluCzfNzUsIL7dgBxVYjc3TJqzny4yAcE1z7vU6bWWhI5A3DjmqTcHHFTqCwGOoqG4RkPJpSYRVtC3ZyqvHU1po6kdvbNc8CRt2mtG3nVlAJx2PvW9CrbRmFWnfVGg7ev0prsABUJfdjA4psjEjjFdLdzntYcJPmB/rViN9xHPFUN2PrViJ/epSuRMt7hn2qNpNrHHWo9/HTmmMeR0570yUSO/vmoWbnpzSkgnBxmoJCFyQRSa0GmPhIznHWnM3UL+dQI2Pm6/jS7gWx+NSloXcQrk8DOe9WIMBTuxx61X5A/woJA/iNNJImTuTlgT1qRV3dD096pCXJAzxS+cyH5VyPWri0ZNMtSp8vY/SqZtg4Jxjtip0ud7YKc96c3t0pySkEZOJTePbwOgqpLERJuAwB29avyja1JC7pIkiMAynj1FYTimbwm0WFihvLS1X7WsBgXaUcEc5zuGKnvJladPLk3gIFLsMFyB1qxDI1tYwBtRaLeuVQQ5IGTVfULZi7TfavtDjaGGzacN90j1FO1kYqV5avT+vI4WbxoJCVhhyoNSw+IBdgI8J+meB9K4628vO0Ae5rTHlQYKyDOMjFeh7JSPlli6sftHZx3W6LCqVHQc1BcTZzngeuazLO+32yhOfWiTzJo29xwaznhqfRnRDM6q6F1JlAPPPpSmVm6A49ah061JK7zwfWujitYVt+AM4qYYTQqWaPqjJttuTuPP1qwZU2iPqp96bNa4YslVWB2kEfNWTpSjojupY+nJJs1I7iJkA3cdMVDc3IXAQjFZbZU4IOO1G7I9qxlWduU9OnGMveTNCO9K9AD6mr1uwlBYferBDgNxVy2uTE2R3qadVp+8XOCa902EHygNRsUnn9ahTUEZQpGM1I80QUHPFdXNGS0Zz2knsQTDa+F7iiOX3xUM86s21Rnmmo3OOvpWDavodCvbUteZk8Z96UN+tQFumeKC3SqQm0i2nr3p7r8hyeappcKrcmm3WoxgY3CtFZIxlU1EVsS+1XkYGsdJ97ZX14Iq4s7KOlTSTvcmpVvoi91PWmuwHHGagjmLYxT39uuK6JbaGUb31HHrz1pXBIAxTVzkE08kYOK55bHTTeo0yMkeOtV5JtwIxUpZcAMcVWmAzwc1zzbsd0FqIfl5BxRnONxJoGSPWnIAMYrA6bliLCj0ouELpxSwgnFWXgyh5x9KtRujKUrMysHJAHQ05Bj7pA9amljCA4PIqujnfzxU8ttCnK5dtiT1bipGb5qqwkhic9eamzzznFdMNjkqbi7gG45NKjkEBSMd6j4B5/+vTS+DW1rHM5FkyY6Cl3nbxVJjzz0p+4hc9qAvctFxg5/Oq8j7j+lV/OLdcZ9qQvggipbBaFgHAxQHAP1qAynHXmm+cT/ACpXHctNIO1V5H5OelQyyngZ61Fvb8KT1HF2LSvjkdKmW4Ude1Z4PU5NNLENz09KXM4hpJmyk4KkKOtNZmJyAeKz45ccjpUhnIXNUp3JcbbFiSTI5piy8YByPTvUCyljh+mKsSWbRadb3nnQukzsgjV8upH94dhSbb2HdKyfU1bdhJbQtfC0CYIiMpYMVz/s9s+tFxPPHJNFIkQZyp3L/dA+UD2rOW7tZY4lvIZt8S7FaJgNw64INSX07NOm5PLXy12JnOFxx+NTzEKOup5Tb6c75OTVp9PZV+Ykgit+3tivAXj6VbOnlhjk/WvTu2fIWMbS4DEMN0x1FahcADA4NXbfTTtx0qwmnArgjPqacW10E436kNlLyAOlaqMhjJyR6Gq0dmo59Km8tjwKfNJkumhTKu3aTkjjNU2C7ySP0q3DZsWJ45qWW2AXOKlxb1Li0tDIlh3fd4qjKhRvatxoiARiqFxESema56tFSV+p3YbFzovyM0OM4zzUgf3zSTW5ByOtRqRnniuGdNxPfo4qNVaFkS8dKsK/mbQTVAP1OamSTgDrUWOrnTRciZRLhvwp8pxyDjFQRxYG9uo6GmvMc8n9K1irLUxlU1LHm/J64qvLeBFyzAKPWs/UL1beNnZsYHrXLx3NzqkrAuUhB4rWEJSOLEYuNP3Vqzc1DW8sY7b5m9qq2vnyybrhiM9hUlnZJGeBk+vrWoIFaP1IrSySONSnUd5M0dLgl8vekbNGOSQMgVogKV+laPw9umlkbTZQm1slWPVf8ai12zXTtWmto5RInXIXHP0rVQUaaqROmE7z9m9yrEoJ4q4kI25NQWisXA2s5PQKMmnTXRLbFGCOD2NNSSjdmtm5WRLamH7Ttn+5jrnFQ3ckSlxGMqD8pqtOcHOefSoN4IOTXLOppY7KdPW9xzy5HelVwV+bIqq+Qc5pTJuGBj6VyNnfEsrwcbuPrVmNASD2qgj8gDNX7fcQDTjqypOyLkaqDxipJm2R9qQMBGMde9MncMmBzxW1kloc/Nd6mRIxaQnPBpr53CnSAlzgcg1HnFcx0ssRNjmpTJjFVVO5Rg804N05raDsc1RXJ2fHNRPIARTGkwe1VZ3IUkGuiMuhwVfd1LRl96BcBkYE9ulY73W3IJxUYvMfxVTTOVYhI1POGOKaJ896zftAbkGlWYE9ayd7mqrX1Lxl5GDzQ02F71SMvPX/AOtSNJnmlsV7Qt+dyMAmnrMpXByDVFGzip3UBMgc96VmUqiLkcsZPPND47AiqK5xgDBHepUkkHbj3p3voNyUdblmNhjBpZWUbQcmolkKA8jB7VXkuA2MH3xVOnKxl9ZhfVloNgjnjtU1sYvNUSsyrn5ioyfwrK+0gN81WbMtdypFCCzswUZ4pKlPsDxdLa5uKmmswxPecj/nkv8AjWimhanrSLd6LYXV3aRhYN6oCdwHcA8VieRaINralFuX0jYjP1roNSvl8L6xGnhbWrvypII5JJFfALEZIxgAito0X9paGE8YtFSevnsZEdmingcVP5aJ2qdULAfzp6Rc88mvQ5bHz5FFHnsRTZUYc4rRhUEduO1I0YfIGKrlYGZzinxqc8VpRWikcVItkB2oasN2KWAF461G5Y9RxWg1sASCOajMQU9OPWp3J0MuSMjJ5qBojWy6A8EYqrJb8Eg1PKUjCuIx6ZJrKuoSoJUYrorm3bsOlUJbc55Xg1jOCZ00puLTRzplYMPWpUuMYPcVdntVJPFZ8tm8Z3LuK55xXJKi9z04Y3SzL6XZaPAOR0qCecp1NVmdVDYOOOtZmpXxiicscDoPeqjBvRiq4lJXRneILo3Vyluh4z82K09PgSKFQBwMVkaVbPK5uJv4jxW/bKEyOo6Vs1yqyPPptzlzyNC3XgZ61aXA49RVaHHX24qRmwRk1jI9GkkWrdWRg8bMhB4YEgipWuHDlndmY9yck0yyRpzwQAPepJ0WPOTkCo5XbQ6lJI3PCetrp+oiaaLzY2Uo6g4OD3B9a63xXoUF3ajW9OZNki+Yy56qDgn65rzCGZQDjqPStW38QXH2E2JuJBbE5MWeK6qVRKm4VFdHFWi3UU6bs+vmiHUWAbKtxVNHPXNPv3EmGBH0qkkuBiuCotdD1KFVNWLhfK4po65NQhx1FSiUHhhxWNjujMlSr9rMqLg96z2wcFe1PQnGfSiOjuW2mjUWfacE5FOedWTGayckkEk9KG3LznINU5shJdyw5G488H0prx7lOOagLHGc0nmsORxUrUpysPfcnFV3n29amabcMsOazp3L8jNWl2OapWSJ3uh3NRNMWHXjFUywUjfnNU7qR2yN2F9BW0E7nmV66tqWLiSJpBGGLuxxgd6oaup05gs+UJ6ZrX0Cx8qT7Y6ZVfuk9vWuO8Z6s2qakzjIij+VB7V6EKV43bPFr4hR2RpW1+W4LAjsavwXG4A47Vwem37xS+WcHJ4zXV28hMYIrKpSsVh8VzI2RKMjmlWUEgHrWWjs+Aqk89a1dPt2K5Yc+9Z+zOr2/cniJZgFGferscZPXrUtpZF2AA5rYg0/aMt1rWnR6szqYnoZsduT64xUU8JU4GR6mugWEIDkYqKWJCegroVGLRzvESOdaFsHdnIqhKGjkwPWuqkhXHQYrLurRWJIHPXFHs0jN1L7mPKvmY6g1f0x2tHjliHzocjjPNOSxb04rQtEaCRXRijoQQw7U1TlJ6FQlFLUrTXdmG3HS3DdSFmYLn6Yqhe30l1P5jqI/lCoijhVHAFdtONUuj5sK3cakAkDOM9yOOlc5qen3M8zyTs7ydCW68USw9TccasI7HbLBg5A6dKYbWTdkZregtw+MjBqY2ac5ArXc4/aWOa+yuCMEgZ/OpooOemR71sywxjkdfeoPKXdg4x9auMC1O423gU+man+zDB4p8CBSQF71cTGDmiUdTOTMyS2POBVCeAknIx71vzFQpGOaoShWIA4Jpcg4NmOYCBkjvQYCRk9K1jED1FNeAY4FTYvmMSW2BIJqlNa5yMe9dCYsZyDVSeMZII+lS4FxkcvcWvOQKrfZiB0GD2NbtzGFz7VXdAVH09aj2dzbm7nNXVhBICGXYw6EVy/iDRrlirRIZYx/dHP5V29+ORgdsVSjkeOQYPHvWDVma6TjZnEW8skX7uQFSOxGK0IZunPWuzlMF3GEureJo+4AA//AFVmXvhWIS/6BcyLG5+QOA2PQZqXJMcYuOxmRTjABJ6dqUz5yc5FVtR0zU9Lk2XttIhPR15Vvoapxysz7VVmbpjFRKJvCobsN6Y0IDYz1qGe9bH3iR3qlHbXMoO2Jh6huKv22h3VztAcKWPA7Cotbqbe0bKiXbISxbj0qCW+OSVJ4rvdN8HLGv7xGuZP4gVxj6E1oTeC9JmAEtm9vKR97kDP4VSa7HNUbezPOLTWFEsa3ZPlE4Yj071anuoGvJDZl/s5b5C/XHvXoUfh3S0tzDcpaKmNhEiZasP/AIRS0kk26ejyhfvDdjZ+dJ2a0RpTnJdTDhfcM7qmLgL2rqLPwnHG4BhaQqDuDSAAVVvPDKwXEjyyFLYMQQr7vyNZyw8t0dtLG9GzCSfAp4uAM1uJ4fsN0Uwkl+zuCeGBP1rHfTYnuGSC5YqG6kchaiVCS3N1i7iG4GPakEpP0qzForMGfzi8Y5GBzWvZaXYmyUSW101yRuXAyD+FCw8mEsZGJzjTc9aie54x0rqINAivZSzxmFfQHaKW/wDBiRKHik3KRkZYjH41KpPoZyxiTs2cZNdkE4P/ANeoJLzYpY+nStC90GXDCCVi4PK9f5VkPoGq3EoSFY2bsDJjP51rCKOWtVm9Uilc6gRljzVP+1DLcKqjlsDFW/8AhF9dmbYtrsycZdwo/PNT6F4WnttWA1VU+UjaEkyCc+o9K7acIbNnkVZVnqos1df1M6boKQINryLtx/OvOJ5RJn1rtvFGm6zqupvbWtoVt4CcSyNtBpNK8ExAiS/m8zABKrwuf6101akIvli7nNClVqatW9Tz6SFmceSGZz0CjJzXV+Hba9mgAuIJEwcZYYruLbSbOzOLZVz7KP51b+zkjkCuaVRy0sdEMOqfvXuZFpYJEoJGTWvawA9OlPSDtj61ciAUe9EYmjRbsECYzWmWDJxj8KyVk2gYyDVqGQt1HArphpozJq+pLKvFVDGxfrwKuEqQTg035eDjmrdgSZTeM5wRUZtyOMAemavE9qUABTnpn86nRCaZXith3AFS2yJDeRSyJlEbJGKGYK2c4HpVrTzE95D5xzFuG7PT8auLM2mRxgi4MjarEyk53MzBvyq5dXFvdzZU7wFClyMbyB1ou0W4ke3vkjjk/gkVQNh9DjqtZurq9veomcEQoDg8ZxXRTq8r1J5Oc7sOiqOxFRSXGeOtRP14NN2nGAecVzJMagiN5MkjBzTASzD196lFsxJOOlTQ2pAyRV6mnupBEuQCTk1NuIH4etSRwnHI/EVIIgTjnP0pO5i2rlJ2JUjFV9hJwBWm1vjtxUEqqoI4pJspMrH5Ac9KhEhYZPHpS3DfLjGQarb2JPFBahckLfUmqswBHr71YznjFQTYz2pMcYmdcKCOnPriqkiYB4yRV6bGaryJ3A/Cs27G/LoY11AWbI/WqTwYPSugKAk7uTVaaAc9M1lJX1Lp6Mwzvj6Zp4nxsBkKKTyoH9Kszw4B/wA4qpt2SA8ED2rnaZ06WN61uoYp7cXAa9tQRuD/AMsVd1EaBc7XbbabB8rJHgn8q5lXiOThskcAdAa2LF7VFY3VkplAyN2SM/TpTv0Zi468ybIHs7W6ni/saa8vCB+8EqALn0BzzVvS7OLz/wB+lwkqHBVI8getbul2+mzPC0qgjZ9zO0Ln0xWi2iW+CbC7ktxx8inKk03Qb95EPEpe62UDFcBXuLBBjqouJCCR+FDTXpEb3MSGNfv/AC5wT70XLPDKLYs5mU5BKAhh9AKbf2z/AGV50DhtvP7zAb04FLlJTvoyjqAjuw3mxRwFASZgec9OBVazszDZ7pJIY95HIyXA9arQ2ot1VrshrhhnYG4/H1qxbR78SSQF1J5Cpu+grOKu9EdijJR30JbmK28hd90blwwx0JA74qWR4PKFvHBJMx6LJ8o+oH9ajshHIwKF5grciOPaqH04rVu9MlvGjuI4gEXghpSOPQA9DWl30Rm5KLtJmRcLBHdLFJA0MZI/eI2EDHt1rRfwpZSQpOdRBeTkFl4HtVg6TcpCSgt4t3zKV5Ye3PeqqXs1lB9neKPI+Xe3PPrT91fFEjnnJfupFK108wXE1vIiyQ5wGgbJP4nkCp4rvF6INMlMcmNr+aPuj2zzUq6Yboectz5bH5mZQF/lUUcEekztM6RSmRgplbOc/j2pJtaWCclJ6u77F+AiE7WuIyQMu7Dk/SqOoaibgOtpcGVvu8L0x71FqOpWjxODHDvI+VVTJNY+nRziAncwyckZwcelKbtojOnFt80vxLUN1PasUhCB/wCJsc8+tVJoZmbzJZwcc/KuKvpPEoDRxqkje5LGsm/upNw+0ODIf4fQVk4Ox0Qqq+g+5cBMSMZGPQcmqKy+W+SAnYmkmv8AYP3andjGfWs1vNnYliTk5puDY/a2ukjTmmRiSWc55wD1+tQBizcZA7DNMhg2jk5q0iYPArWMbGEpOWjJoRtHPX1qeNQQMdajgTJBxxV2KPp61tGNyHoCQg+3rUywY4p0ZwOlWIyc4GPyrdU1YzuyrJB7fjQisO/WrxXcOlSQ2zMelFrFLzKoBCjOaMZA/rWt9hXbnkH0qnPb7WJA4puLCLTKmwseKJEKgAjnFScqT0odsj0NS0Xy3KEqHIAqS2R94C5bPQVYMavjtVuxAhu4yzAAHGT2OODQiZQsix9jJUK8sKydNpPI/HpWRqFo8MrB8gjjaR0roo5VS6jyyrtUI0JU7jxyMY5z6+9VNXIeVV/iVArc9/8APH4Vpe6MY3TNhCd3Wnk4IA70UVURMsxn5cVZQY4oorQxkIDl8H1p4OWPFFFRISEckCqNwT0oopLYuO5nyctg+tNwBnjpRRS6m/QYeh9KrOdxI6UUUMcdytL781BJ39BRRWMjVED8BsVD94HNFFSBFOikEelZEv3+eaKKxludEdiu3y8jv2rU0e8k8xA2HXpg80UVC3Jn8LL15I0dwwXiPGQnofasu4vbiObYkzrjnKsRRRTqaI0w+qRo2V9cNN5hlYsihlLHP86fcanJO/2Z1zhsly2c/hRRUwehVaEea9i/p0kDwywmD5vMyH3dBjpjFXLedDeLCYh5YTIAYjBPFFFXHdHPIhvLpNJglls4QgXnYGwpJos9SvZlilmlQxspcxKm0fzoopzbUkkDhFxu1qXJryS6uI9zSIcD7jkCp7jTraVAJI8so3bu5ooq3q2czbjFcpUlbyrVvK+XAOM81il3urfdI2MNg7ep/GiiokVTd1dmnp1rCkBkZAzMdoJ7f41Uv5cwFVUAYI9aKKuy5UZKTlLU5m5vMDZHGqEc7h1qm7An7vLckmiisH0OtbCKoOPerEag0UVqkT1JkqdF4GTmiiq6CW5dgQY/DNW0VSo459aKK0hsJ7j1Uc1Yj459eKKK0QEsXzYrTslBbmiimtyJ7Gi0ahM47Vk3oGcgYoorR7GdLczQATyKQxrj9KKKxZ2oYoAPFK7Fhg0UUkKYJdXC/IJ5AuMY3Up5U8UUVSM2j//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erosions on the&nbsp;palate in a patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions on the tongue and lips are present in this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21800=[""].join("\n");
var outline_f21_18_21800=null;
var title_f21_18_21801="Microbiology and pathogenesis of Klebsiella pneumoniae infection";
var content_f21_18_21801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Microbiology and pathogenesis of Klebsiella pneumoniae infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Wen-Liang Yu, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Yin-Ching Chuang, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21801/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/18/21801/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Klebsiella pneumoniae is a gram-negative, lactose-fermenting, non-motile, aerobic rod-shaped bacterium. It has been a known human pathogen since it was first isolated in the late nineteenth century by Edwin Klebs.",
"   </p>",
"   <p>",
"    The microbiology, pathogenesis, and epidemiology of infections due to K. pneumoniae will be reviewed here. The epidemiology, clinical manifestations, diagnosis, and treatment of infections due to this organism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;K. pneumoniae has three subspecies with homologous DNAs but different biochemical reactions: K. pneumoniae subsp pneumoniae, K. pneumoniae subsp ozaenae, and K. pneumoniae subsp rhinoscleromatis. For the remainder of this topic review, K. pneumoniae will specifically refer to K. pneumoniae subsp pneumoniae.",
"   </p>",
"   <p>",
"    The following are the characteristic biochemical reactions of the different organisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      K. pneumoniae is lactose fermenting, H2S- and indole-negative, has a positive Voges-Proskauer (VP) reaction, is capable of growth in KCN and using citrate as a sole carbon source, and is incapable of growth at 10&ordm;C.",
"     </li>",
"     <li>",
"      The other two subspecies (ozaenae and rhinoscleromatis) are indole-negative with a negative VP reaction.",
"     </li>",
"     <li>",
"      Klebsiella oxytoca, which is one of the other species of the genus, is indole-positive, has a positive VP reaction, and is able to grow at 10&ordm;C.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five major virulence factors of K. pneumoniae are known to contribute to the pathogenesis of infection: capsular serotype, hypermucoviscosity phenotype, lipopolysaccharide, siderophores, and pili (",
"    <a class=\"graphic graphic_table graphicRef79361 \" href=\"UTD.htm?31/21/32091\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/1\">",
"     1",
"    </a>",
"    ]. The degree of virulence conferred by K. pneumoniae can be determined by several methods (",
"    <a class=\"graphic graphic_table graphicRef68146 \" href=\"UTD.htm?9/58/10156\">",
"     table 2",
"    </a>",
"    ). A single strain of K. pneumoniae can express an inconsistent degree of virulence in different virulence testing assays.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Capsular serotypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The capsular polysaccharide antigens of K. pneumoniae can be classified into 77 serotypes. Serotype prevalence varies widely in different regions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/2-9\">",
"     2-9",
"    </a>",
"    ]. Worldwide, K2 is the most common capsular serotype of human clinical isolates, usually from urine or sputum specimens [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/2\">",
"     2",
"    </a>",
"    ]. However, in different series, serotypes 2, 21, and 55 were most common in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/2\">",
"     2",
"    </a>",
"    ], and 21, 2, and 55 were most common in North America [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/2\">",
"     2",
"    </a>",
"    ]; K1 was the predominant capsular serotype in bacteremia, liver abscess, and septic endophthalmitis isolates in Taiwan [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/3-6\">",
"     3-6",
"    </a>",
"    ] and in liver abscess isolates in Korea [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/7\">",
"     7",
"    </a>",
"    ]; and K54 was the major serotype from urinary, sputum, and blood isolates in Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The K1 and K2 isolates are generally more virulent than",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    isolates in terms of lethality for a mouse when injected intraperitoneally [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/10\">",
"     10",
"    </a>",
"    ]. The discrepancies in the degree of virulence observed among strains with different capsule types may be explained by two major mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Macrophages with the lectin or mannose receptor can recognize the capsular sugar sequences of",
"      <span class=\"nowrap\">",
"       mannose-alpha-2/3-mannose",
"      </span>",
"      or",
"      <span class=\"nowrap\">",
"       L-rhamnose-alpha-2/3-L-rhamnose,",
"      </span>",
"      particular of",
"      <span class=\"nowrap\">",
"       non-K1/K2",
"      </span>",
"      antigens. Subsequent macrophage-mediated ingestion and killing of organisms is nonopsonic and known as lectinophagocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. The K1 or K2 antigens lack these mannose or rhamnose sequences, which can protect these isolates from lectinophagocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Strains of K. pneumoniae with K1 or K2 capsule serotypes are more often hypermucoviscous than",
"      <span class=\"nowrap\">",
"       non-K1/K2",
"      </span>",
"      strains [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'RmpA gene'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some capsular serotypes such as K1, K2, and K25 may contribute to host infection by protecting the organism against phagocytosis by neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In addition, the capsular polysaccharide may play an important role in the development of respiratory tract infection by protecting against phagocytosis by alveolar macrophages [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypermucoviscosity phenotype",
"    </span>",
"    &nbsp;&mdash;&nbsp;K. pneumoniae strains possess the hypermucoviscosity phenotype if they are capable of producing a mucoviscous exopolysaccharide web. In the microbiology laboratory, these strains grow in sticky colonies on agar plates and are identified by a string test [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/17\">",
"     17",
"    </a>",
"    ]. A positive string test is indicated by a &gt;5 mm viscous string from the colony on an agar plate when stretched by a standard bacteriologic loop (",
"    <a class=\"graphic graphic_picture graphicRef53292 \" href=\"UTD.htm?37/43/38576\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"     18",
"    </a>",
"    ]. The clinically invasive nature of some K. pneumoniae strains correlates with these microbiologic characteristics.",
"   </p>",
"   <p>",
"    Strains with the hypermucoviscosity phenotype or with enhanced production of polysaccharide capsule independent of capsular K serotypes are more resistant to complement-mediated serum killing than those without the hypermucoviscosity phenotype or those with reduced capsule production [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. The clinical importance of these observations was illustrated in a study in which hypermucoviscosity correlated with high serum resistance and was present in 52 of 53 strains causing invasive infection (liver abscess) compared with 9 of 52 noninvasive strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of clinical studies have demonstrated a significant association between the hypermucoviscosity phenotype and a destructive tissue abscess syndrome, including abscesses in the liver",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5,20-24\">",
"     5,20-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These relationships were illustrated in a review of 151 K. pneumoniae isolates from patients with bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hypermucoviscosity phenotype was found in 38 percent. The rate was higher with community-acquired compared with nosocomial infections (49 versus 15 percent), a finding that is consistent with the association of the tissue abscess syndrome with community-acquired infections. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Primary liver abscess'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Among 95 isolates from secondary bacteremia (excluding five isolates from mixed infections), a hypermucoviscosity phenotype was found in a significantly higher proportion of isolates from any abscess site (eg, liver, neck) compared with nonabscess sites such as the urinary tract or to isolates from primary bacteremia (85 versus 23 and 25 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The outer layer of the capsule of most K. pneumoniae consists of a network structure of fine fibers derived from capsular polysaccharide [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/25\">",
"     25",
"    </a>",
"    ], known as the exopolysaccharide web. This structure is encoded by the capsular polysaccharide (cps) gene cluster on the chromosome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/26\">",
"     26",
"    </a>",
"    ] and is positively regulated by plasmid-mediated genes, including rmpA (regulator of mucoid phenotype gene A) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/26-28\">",
"     26-28",
"    </a>",
"    ], rmpA2 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/29,30\">",
"     29,30",
"    </a>",
"    ] and magA (mucoid associated gene A) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     RmpA gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;The capsule of K. pneumoniae is encoded by the capsular polysaccharide (cps) gene cluster [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/26\">",
"     26",
"    </a>",
"    ], which may be regulated by plasmid-born rmpA and rmpA2 genes to enhance extracapsular polysaccharide synthesis and produce the hypermucoviscosity phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/26-30\">",
"     26-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rmpA gene was significantly associated with a hypermucoviscosity phenotype, being found in 90 percent of such isolates compared with 22 percent of isolates without a hypermucoviscosity phenotype. On the other hand, the hypermucoviscosity phenotype occurred in only 81 percent of rmpA-positive isolates. These observations suggest that other factors control full expression of rmpA or the hypermucoviscosity phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     MagA gene",
"    </span>",
"    &nbsp;&mdash;&nbsp;MagA encodes a 43 kD outer membrane protein. The magA gene is located within an operon that is specific to the serotype K1 capsular polysaccharide (cps) gene cluster [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/31-33\">",
"     31-33",
"    </a>",
"    ], and the operon containing magA is responsible for the K1 capsular serotype [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/34\">",
"     34",
"    </a>",
"    ]. In one report, for example, serotype K1 was present in all 36 magA-positive strains compared to none of 38 magA-negative strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/34\">",
"     34",
"    </a>",
"    ]. Restriction of magA to serotype K1 strains has also been noted in other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5,35,36\">",
"     5,35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study using transposon mutagenesis to identify candidate virulence genes demonstrated that magA-positive strains had a mucoviscous exopolysaccharide web, resisted phagocytosis, and produced liver abscesses and meningitis in mice [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"     18",
"    </a>",
"    ]. On the other hand, magA-negative mutants of serotype K1 strains lacked the exopolysaccharide web, became susceptible to phagocytosis, and were not virulent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Relationship between magA and rmpA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have evaluated the relationship among magA, rmpA, and the hypermucoviscosity phenotype:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hypermucoviscosity phenotype is not confined to magA-positive isolates (ie, serotype K1 strains) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20,36\">",
"       20,36",
"      </a>",
"      ] nor is it found in all magA-positive isolates [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      RmpA can be responsible for the hypermucoviscosity phenotype of magA-negative isolates (such as K2 or other non-K1 serotype strains) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"       20",
"      </a>",
"      ], and rmpA-negative isolates of magA-positive strains may lack the hypermucoviscosity phenotype [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The k2A gene is seen only in serotype K2 strains and corresponds to the magA region in the cps gene cluster in serotype K1 isolates [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/35\">",
"       35",
"      </a>",
"      ]. Thus, k2A in serotype K2 isolates may play a similar pathogenetic role as magA in serotype K1 isolates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A report of 73 K. pneumoniae isolates from liver abscess evaluated the relationship between rmpA carriage and capsule serotype [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5\">",
"     5",
"    </a>",
"    ]. RmpA carriage was found in all 49 K1 or K2 isolates compared to 16 of 24",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    isolates, suggesting that",
"    <span class=\"nowrap\">",
"     K1/K2",
"    </span>",
"    isolates are generally more hypermucoviscous than",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    isolates. In addition,",
"    <span class=\"nowrap\">",
"     K1/K2",
"    </span>",
"    isolates had more resistance to phagocytosis than rmpA-positive",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    isolates. The latter observation is consistent with other studies showing that the mucoid phenotype mediated by the plasmid-encoded rmpA gene is an important virulence factor in addition to the capsule in K1 and K2 K. pneumoniae isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, the rmpA gene is a positive regulator of extracapsular polysaccharide synthesis and confers a hypermucoviscosity phenotype in most isolates. In K1 isolates, the magA gene is essential for the formation of the exopolysaccharide web, a process that can be enhanced by rmpA. Capsular serotypes K1 and K2 also may contribute to virulence, independent of rmpA and magA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Primary liver abscess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary liver abscess refers to infections that occur in the absence of a history of hepatobiliary disease. Most cases of K. pneumoniae primary liver abscess have been reported in Taiwan and are community-acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4-6,18,20,21,34,37-43\">",
"     4-6,18,20,21,34,37-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Community-acquired primary liver abscess has also been described in other countries in East Asia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5,7,44-46\">",
"     5,7,44-46",
"    </a>",
"    ], in Asian patients living in other countries [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/22,47-49\">",
"     22,47-49",
"    </a>",
"    ], in South Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/50\">",
"     50",
"    </a>",
"    ], and, much less often, in non-Asian patients in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/47,48,51,52\">",
"     47,48,51,52",
"    </a>",
"    ], particularly Hispanics [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/47,52\">",
"     47,52",
"    </a>",
"    ], and Spain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link\">",
"     \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A minority of patients with K. pneumoniae liver abscess develop metastatic infections, as most often manifested by endophthalmitis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4,6,18,21,35,37\">",
"     4,6,18,21,35,37",
"    </a>",
"    ]. In one series, for example, metastatic infection occurred in 23 of 177 patients (13 percent) with K. pneumoniae liver abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link&amp;anchor=H8#H8\">",
"     \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\", section on 'Metastatic infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MagA-positivity has been strongly associated with primary community-acquired liver abscess in humans and is less often present in other K. pneumoniae infections [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18,34\">",
"     18,34",
"    </a>",
"    ]. The association with magA was illustrated in a report in which 35 of 42 (83 percent) K. pneumoniae strains from patients with primary liver abscess were magA-positive compared with only 1 of 32 strains associated with other types of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/34\">",
"     34",
"    </a>",
"    ]. Similar findings were noted in another study in which magA was significantly more prevalent in invasive strains that caused primary liver abscess compared with noninvasive strains that did not (98 versus 28 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, lower rates of magA (K1 capsular serotype)-positivity have been noted in other series of patients with liver abscess, with values ranging from 34 to 63 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4,6,7,20,21,35\">",
"     4,6,7,20,21,35",
"    </a>",
"    ], and rmpA-positive isolates have predominated in several series [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5,6,20\">",
"     5,6,20",
"    </a>",
"    ]. The discrepancy in findings may be in part related to inconsistent distinction between primary and secondary liver abscess. As an example, a liver abscess in a patient with a small silent gallstone is more likely to represent a primary infection.",
"   </p>",
"   <p>",
"    MagA and the hypermucoviscosity phenotype are much less common in K. pneumoniae secondary liver abscess as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a review of 129 patients with liver abscess in which 53 were considered primary and 76 secondary [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"       6",
"      </a>",
"      ]. The rate of K1 positivity was much higher in the primary abscesses (81 versus 42 percent). As noted above, magA is associated with the K1 capsular serotype [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/31-34\">",
"       31-34",
"      </a>",
"      ]. Thus, prior studies showing an association between K1 and liver abscess, particularly if complicated by endophthalmitis, may have reflected magA-positive strains.",
"     </li>",
"     <li>",
"      In two series, the hypermucoviscosity phenotype was present in 40 of 51 cases of primary liver abscess compared with 9 of 39 cases of cholangitis (78 versus 23 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some studies have suggested that the K1 or K2 capsular serotype is a more important virulence determinant for K. pneumoniae liver abscess than magA or rmpA [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5\">",
"     5",
"    </a>",
"    ] and that genotype K1 may be particularly associated with the risk of metastatic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ]. Such infections can occur in patients without any underlying predisposing medical conditions, which is a reflection of the virulent nature of the K1 strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ]. In addition, serum resistance assays have shown that K1 isolates were significantly more virulent than K2 or other isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible mechanism for the role of the K1 capsular serotype in virulence is that chromosomal regions with additional virulence genes (magA,",
"    <span class=\"nowrap\">",
"     kfu/PTS",
"    </span>",
"    [a regulator of iron uptake], and allS) are selectively present on the serotype K1 genome; genotype K1 strains with all three genomic regions are strongly associated with primary liver abscess and metastatic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/43\">",
"     43",
"    </a>",
"    ]. A high prevalence of the plasmid-borne rmpA gene also may contribute to the virulence of K1 strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Another study in Taiwan also determined the prevalence of these virulence factors among 50 K. pneumoniae isolates causing primary liver abscesses. In general the prevalence of hypermucoviscosity phenotype, plasmid-born rmpA aerobactin, kfu, and allS genes is higher in K1 isolates than K2 and other",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    isolates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both the K1 capsular serotype and the hypermucoviscosity phenotype are associated with community-acquired rather than nosocomial K. pneumoniae infection, which could explain why isolates from primary liver abscess are almost exclusively acquired in the community [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20,38\">",
"     20,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diabetes mellitus is a common risk factor for primary K. pneumoniae liver abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4,7,39-41\">",
"     4,7,39-41",
"    </a>",
"    ] being present in 78 percent of 134 patients in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4\">",
"     4",
"    </a>",
"    ]. The data are conflicting as to whether diabetes is [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/4,39,41\">",
"     4,39,41",
"    </a>",
"    ] or is not [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ] an independent risk factor for metastatic infection. The high prevalence of diabetes or impaired fasting glucose with K. pneumoniae liver abscess is not seen with other causes of liver abscess (eg, 75 versus 5 percent with polymicrobial liver abscess, and 70 versus 33 percent with non-K. pneumoniae liver abscess in two large series) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Poor glycemic control reversibly impairs phagocytosis of K1 and K2 strains of K. pneumoniae but not other strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/55\">",
"     55",
"    </a>",
"    ]. However, in the series of 177 cases of K. pneumoniae pyogenic liver abscess cited above, diabetes was significantly less common in K1 compared with non-K1 strains (54 versus 70 percent) and the median level of hemoglobin A1c was significantly lower in patients infected with K1 strains, indicating better glycemic control [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ]. Similarly, the prevalence of diabetes mellitus was lower in patients with",
"    <span class=\"nowrap\">",
"     K1/K2",
"    </span>",
"    primary liver abscess than with",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    liver abscess (53 versus 86 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/56\">",
"     56",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     K1/K2",
"    </span>",
"    isolates are virulent strains capable of causing illness among diabetic and non-diabetic hosts. These observations suggest that optimized glucose control may not be sufficient for reducing the risk of",
"    <span class=\"nowrap\">",
"     K1/K2",
"    </span>",
"    liver abscess in diabetic patients, but may be helpful in reducing",
"    <span class=\"nowrap\">",
"     non-K1/K2",
"    </span>",
"    liver abscess, which accounted for 12 (39 percent) of 31 cases of primary liver abscess in diabetic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Lipopolysaccharide",
"    </span>",
"    &nbsp;&mdash;&nbsp;K. pneumoniae serum resistance is mainly conferred by the lipopolysaccharide O side chain, which can impede C1q or C3b from binding to the bacterial cell membrane, thereby protecting the organism from subsequent complement-mediated membrane damage and cell death [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. This effect has been demonstrated in mutant strains in which lack of the lipopolysaccharide O side chain is associated with sensitivity to complement-mediating killing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The capsule in these strains played no role in serum resistance. However, some clinical K. pneumoniae isolates that lack the lipopolysaccharide O side chain retain resistance to complement-mediating killing if they are heavily encapsulated [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Hypermucoviscosity phenotype'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Klebsiella lipopolysaccharide may also contribute to virulence by other mechanisms. These include increasing lethality in pulmonary infection by enhancing the propensity for bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/61\">",
"     61",
"    </a>",
"    ], and acting as an endotoxin, by triggering cytokine pathways leading to the sepsis syndrome and septic shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=see_link\">",
"     \"Pathophysiology of sepsis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Siderophores",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron is an essential factor in the growth of Enterobacteriaceae such as Klebsiella [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/62\">",
"     62",
"    </a>",
"    ]. Because of the scarcity of iron in the microenvironment, K. pneumoniae and other bacteria have developed multiple mechanisms to enhance iron uptake. These include synthesis of iron chelators (siderophores), such as enterobactin (also called enterochelin) and aerobactin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/62-64\">",
"     62-64",
"    </a>",
"    ], the aerobactin receptor to introduce exogenous aerobactin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/65\">",
"     65",
"    </a>",
"    ], and the kfu iron uptake system [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Enterobactin is the main iron uptake system and is synthesized by almost all K. pneumoniae strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. In contrast, aerobactin synthesis has been infrequently found (less than 10 percent of strains) in most reports [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/66-69\">",
"     66-69",
"    </a>",
"    ]. In a study of nine K. pneumoniae isolates with capsular serotype K1 or K2, all produced enterobactin, but only those that produced aerobactin were virulent, defined as an LD50 of less than 10(3) microorganisms [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/64\">",
"     64",
"    </a>",
"    ]. Furthermore, transfer of the aerobactin gene into an avirulent strain enhanced virulence by 100-fold.",
"   </p>",
"   <p>",
"    Both the aerobactin and rmpA genes, which as noted above are significantly associated with a hypermucoviscosity phenotype, are located on a 180-kilobase plasmid [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/28\">",
"     28",
"    </a>",
"    ]. This is consistent with the finding in a review of 241 blood isolates of K. pneumoniae that all 15 isolates (6 percent) producing aerobactin were associated with the hypermucoviscosity phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/69\">",
"     69",
"    </a>",
"    ]. However, 20 percent of the isolates had a hypermucoviscosity phenotype. Thus, although the aerobactin gene was always associated with the rmpA gene, the rmpA gene was not always associated with the aerobactin gene indicating that some rmpA-encoding plasmids do not contain the aerobactin gene.",
"   </p>",
"   <p>",
"    These observations suggest that the association of aerobactin with virulence could be mediated at least in part by the concurrent presence of the mucoid phenotype. This issue was addressed in knockout experiments in a K2 serotype K. pneumoniae strain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/28\">",
"     28",
"    </a>",
"    ]. RmpA-negative mutants were 1000 times less virulent than wild-type strains but still 100 times more virulent than the plasmid-less rmpA-negative and aerobactin-negative strains.",
"   </p>",
"   <p>",
"    The latter observation supports a direct role for aerobactin-mediated iron uptake in virulence in the minority of K. pneumoniae strains that produce aerobactin. Further support for the role of iron uptake in virulence in K. pneumoniae comes from a study in which the kfu iron uptake system was associated with liver abscess formation and distant metastatic infection such as endophthalmitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/43\">",
"     43",
"    </a>",
"    ]. In the series of 177 cases of K. pneumoniae liver abscess cited above, kfu was found in 97 percent of K1 strains but in no K2 strains, which may contribute to metastatic infection (eg, endophthalmitis) being relatively rare with K2 strains [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pili (fimbriae)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strains of K. pneumoniae express two morphologically and functionally distinct filaments: type 1 and the type 3 pili [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/70\">",
"     70",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Type 1 pili are heteropolymeric mannose-binding fibers produced by all members of the Enterobacteriaceae family, which mediate adherence to many types of epithelial cells like the bladder epithelium [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/71\">",
"       71",
"      </a>",
"      ]. In a review of 151 K. pneumoniae blood isolates, the type 1 fimbrial adhesion gene (fimH) was present in all but three (98 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The type 3 fimbrial adhesion protein (MrkD adhesin) plays a central role in the virulence of K. pneumoniae by attaching to host cells, such as of the urogenital, respiratory, and intestinal tracts [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/72\">",
"       72",
"      </a>",
"      ]. This can result in bacterial colonization, subsequent proliferation on the host mucosal surfaces, and clinical infection such as pyelonephritis or pneumonia. Type 3 pili are also required for biofilm formation by K. pneumoniae on plastics and human extracellular matrix, leading to the formation of treatment-resistant biofilm on indwelling plastic devices, such as intravenous and urinary catheters [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/73,74\">",
"       73,74",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These effects of pili may be counteracted by host responses. As an example, binding of the bacteria to the mucus or epithelial cells of the host may trigger lectinophagocytosis by macrophages, leading to intracellular killing of the bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Subsequent invasion of the bacteria into the underlying tissue or the bloodstream may also be hampered by complement-mediated serum killing. Thus, survival and growth of pathogenic bacteria requires the other virulence factors described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Virulence of ESBL-producing strains",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissemination or outbreak of extended-spectrum beta-lactamase (ESBL)-producing K. pneumoniae strains has been reported worldwide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted in the preceding section, fimbriae contribute to the virulence of K. pneumoniae. A specific fimbria, called KPF-28, has been found in the great majority of ESBL-producing K. pneumoniae, and the plasmid encoding the ESBL enzyme is involved in KPF-28 expression [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/75\">",
"     75",
"    </a>",
"    ]. KPF-28 promotes adherence and bowel colonization of ESBL-producing K. pneumoniae, enhancing the likelihood of spread and nosocomial outbreaks.",
"   </p>",
"   <p>",
"    Except for fimbriae, ESBL-producing K. pneumoniae have a low prevalence of the other Klebsiella virulence factors described above, including the hypermucoviscosity phenotype and aerobactin. This was illustrated in a report of 190 ESBL-producing K. pneumoniae clinical isolates from France: only 7 percent had a hypermucoviscosity phenotype, 4 percent produced aerobactin, and 2 percent had both factors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The low rate of these virulence factors suggests that ESBL-producing K. pneumoniae might have reduced virulence. The data have been conflicting in other studies as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Support for reduced virulence comes from two studies from Taiwan in which ESBL-producing K. pneumoniae were not associated with invasive primary liver abscess [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/77,78\">",
"       77,78",
"      </a>",
"      ]. The infections were primarily nosocomial [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/77\">",
"       77",
"      </a>",
"      ], which rarely cause tissue abscesses due at least in part to a much lower prevalence of the hypermucoviscosity phenotype (15 versus 49 percent with community-acquired isolates in one report) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Primary liver abscess'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a review from five European countries, ESBL-producing K. pneumoniae strains had a significantly higher rate of resistance to the bactericidal effect of serum than non-ESBL-producing strains (30 versus 18 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/79\">",
"       79",
"      </a>",
"      ]. In a second analysis from the same group, the ESBL-producing strains had a higher rate of capsular serotype K2; serotype K1 was rare [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/15\">",
"       15",
"      </a>",
"      ]. After exclusion of the",
"      <span class=\"nowrap\">",
"       K1/K2",
"      </span>",
"      isolates which, as noted above, are associated with the hypermucoviscosity phenotype, the rate of serum resistance was similar in the ESBL- and non-ESBL-producing strains (about 12 percent).",
"      <br/>",
"      <br/>",
"      The cause of serum resistance in these isolates is not well understood since the hypermucoviscosity phenotype and aerobactin are uncommon in Europe [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/76\">",
"       76",
"      </a>",
"      ], a linkage to the lipopolysaccharide O1 serotype is unclear [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/79\">",
"       79",
"      </a>",
"      ], and the ESBL-encoding plasmid was not involved [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21801/abstract/79\">",
"       79",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Hypermucoviscosity phenotype'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43831948\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Klebsiella pneumoniae is a gram-negative, lactose-fermenting, nonmotile, aerobic rod-shaped bacterium. There are three subspecies differentiated by distinct biochemical reactions: K. pneumonia subspecies pneumoniae, ozaenae, and rhinoscleromatis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Five major virulence factors of K. pneumoniae are known to contribute to the pathogenesis of infection. These are the capsular serotype, hypermucoviscosity phenotype, lipopolysaccharide, siderophores, and pili (",
"      <a class=\"graphic graphic_table graphicRef79361 \" href=\"UTD.htm?31/21/32091\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Isolates with K1 and K2 capsular serotypes are generally more virulent than",
"      <span class=\"nowrap\">",
"       non-K1/K2",
"      </span>",
"      isolates of K. pneumoniae. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Capsular serotypes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The hypermucoviscosity phenotype is characterized by the ability to produce a mucoviscous exopolysaccharide web and growth in sticky colonies on agar plates. Clinical studies suggest that formation of destructive tissue abscesses, including liver abscesses, is associated with K. pneumoniae strains with a hypermucoviscosity phenotype. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Hypermucoviscosity phenotype'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=see_link\">",
"       \"Invasive liver abscess syndrome caused by Klebsiella pneumoniae\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The lipopolysaccharide O side chain can impede complement binding to the K. pneumoniae cell membrane and thus protect the organism from complement-mediated membrane damage and cell death. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Lipopolysaccharide'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      K. pneumoniae has developed multiple mechanisms to enhance iron uptake, including the synthesis of iron chelators, or siderophores. One of these, aerobactin, is associated with high virulence in mouse virulence assays. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Siderophores'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pili, or fimbriae, mediate adherence of K. pneumoniae to host cells, including those of the urogenital, respiratory, and intestinal tracts, but their effects may be counteracted by host responses. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pili (fimbriae)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A specific fimbria, called KPF-28, which promotes adherence and bowel colonization, has been found in the great majority of extended-spectrum beta-lactamase producing K. pneumoniae. Otherwise, these resistant strains generally have a low prevalence of the other K. pneumoniae virulence factors. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Virulence of ESBL-producing strains'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/1\">",
"      Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/2\">",
"      Cryz SJ Jr, Mortimer PM, Mansfield V, Germanier R. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 1986; 23:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/3\">",
"      Fung CP, Hu BS, Chang FY, et al. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis 2000; 181:2075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/4\">",
"      Fung CP, Chang FY, Lee SC, et al. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 2002; 50:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/5\">",
"      Yeh KM, Kurup A, Siu LK, et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 2007; 45:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/6\">",
"      Fang CT, Lai SY, Yi WC, et al. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007; 45:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/7\">",
"      Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007; 54:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/8\">",
"      Jenney AW, Clements A, Farn JL, et al. Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol 2006; 44:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/9\">",
"      Blanchette EA, Rubin SJ. Seroepidemiology of clinical isolates of Klebsiella in Connecticut. J Clin Microbiol 1980; 11:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/10\">",
"      Mizuta K, Ohta M, Mori M, et al. Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infect Immun 1983; 40:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/11\">",
"      Athamna A, Ofek I, Keisari Y, et al. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 1991; 59:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/12\">",
"      Ofek I, Goldhar J, Keisari Y, Sharon N. Nonopsonic phagocytosis of microorganisms. Annu Rev Microbiol 1995; 49:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/13\">",
"      Kabha K, Nissimov L, Athamna A, et al. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun 1995; 63:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/14\">",
"      Lin JC, Chang FY, Fung CP, et al. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect 2004; 6:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/15\">",
"      Sahly H, Aucken H, Benedi VJ, et al. Impairment of respiratory burst in polymorphonuclear leukocytes by extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis 2004; 23:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/16\">",
"      Cort&eacute;s G, Borrell N, de Astorza B, et al. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 2002; 70:2583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/17\">",
"      Kawai T. Hypermucoviscosity: an extremely sticky phenotype of Klebsiella pneumoniae associated with emerging destructive tissue abscess syndrome. Clin Infect Dis 2006; 42:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/18\">",
"      Fang CT, Chuang YP, Shun CT, et al. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004; 199:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/19\">",
"      Alvarez D, Merino S, Tom&aacute;s JM, et al. Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infect Immun 2000; 68:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/20\">",
"      Yu WL, Ko WC, Cheng KC, et al. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin Infect Dis 2006; 42:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/21\">",
"      Lee HC, Chuang YC, Yu WL, et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med 2006; 259:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/22\">",
"      Nadasy KA, Domiati-Saad R, Tribble MA. Invasive Klebsiella pneumoniae syndrome in North America. Clin Infect Dis 2007; 45:e25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/23\">",
"      Liao PY, Chiang WC, Chen SY, et al. Rapidly fatal gas-forming pyogenic psoas abscess caused by Klebsiella pneumoniae. Clin Infect Dis 2007; 44:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/24\">",
"      Ku YH, Chuang YC, Yu WL. Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess. J Microbiol Immunol Infect 2008; 41:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/25\">",
"      Amako K, Meno Y, Takade A. Fine structures of the capsules of Klebsiella pneumoniae and Escherichia coli K1. J Bacteriol 1988; 170:4960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/26\">",
"      Nassif X, Honor&eacute; N, Vasselon T, et al. Positive control of colanic acid synthesis in Escherichia coli by rmpA and rmpB, two virulence-plasmid genes of Klebsiella pneumoniae. Mol Microbiol 1989; 3:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/27\">",
"      Arakawa Y, Ohta M, Wacharotayankun R, et al. Biosynthesis of Klebsiella K2 capsular polysaccharide in Escherichia coli HB101 requires the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2). Infect Immun 1991; 59:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/28\">",
"      Nassif X, Fournier JM, Arondel J, Sansonetti PJ. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 1989; 57:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/29\">",
"      Wacharotayankun R, Arakawa Y, Ohta M, et al. Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun 1993; 61:3164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/30\">",
"      Lai YC, Peng HL, Chang HY. RmpA2, an activator of capsule biosynthesis in Klebsiella pneumoniae CG43, regulates K2 cps gene expression at the transcriptional level. J Bacteriol 2003; 185:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/31\">",
"      Struve C, Bojer M, Nielsen EM, et al. Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1. J Med Microbiol 2005; 54:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/32\">",
"      Yeh KM, Chang FY, Fung CP, et al. magA is not a specific virulence gene for Klebsiella pneumoniae strains causing liver abscess but is part of the capsular polysaccharide gene cluster of K. pneumoniae serotype K1. J Med Microbiol 2006; 55:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/33\">",
"      Yeh KM, Chang FY, Fung CP, et al. Serotype K1 capsule, rather than magA per se, is really the virulence factor in Klebsiella pneumoniae strains that cause primary pyogenic liver abscess. J Infect Dis 2006; 194:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/34\">",
"      Chuang YP, Fang CT, Lai SY, et al. Genetic determinants of capsular serotype K1 of Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 2006; 193:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/35\">",
"      Yu WL, Fung CP, Ko WC, et al. Polymerase chain reaction analysis for detecting capsule serotypes K1 and K2 of Klebsiella pneumoniae causing abscesses of the liver and other sites. J Infect Dis 2007; 195:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/36\">",
"      Turton JF, Englender H, Gabriel SN, et al. Genetically similar isolates of Klebsiella pneumoniae serotype K1 causing liver abscesses in three continents. J Med Microbiol 2007; 56:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/37\">",
"      Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/38\">",
"      Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002; 162:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/39\">",
"      Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998; 26:1434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/40\">",
"      Yang CC, Yen CH, Ho MW, Wang JH. Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae. J Microbiol Immunol Infect 2004; 37:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/41\">",
"      Cheng DL, Liu YC, Yen MY, et al. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 1991; 151:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/42\">",
"      Yang CC, Chen CY, Lin XZ, et al. Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol 1993; 88:1911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/43\">",
"      Ma LC, Fang CT, Lee CZ, et al. Genomic heterogeneity in Klebsiella pneumoniae strains is associated with primary pyogenic liver abscess and metastatic infection. J Infect Dis 2005; 192:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/44\">",
"      Lee KH, Hui KP, Tan WC, Lim TK. Klebsiella bacteraemia: a report of 101 cases from National University Hospital, Singapore. J Hosp Infect 1994; 27:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/45\">",
"      Kang CI, Kim SH, Bang JW, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006; 21:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/46\">",
"      Okano H, Shiraki K, Inoue H, et al. Clinicopathological analysis of liver abscess in Japan. Int J Mol Med 2002; 10:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/47\">",
"      Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 2004; 39:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/48\">",
"      Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 2005; 100:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/49\">",
"      Fang FC, Sandler N, Libby SJ. Liver abscess caused by magA+ Klebsiella pneumoniae in North America. J Clin Microbiol 2005; 43:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/50\">",
"      Yu VL, Hansen DS, Ko WC, et al. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis 2007; 13:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/51\">",
"      Harris PJ, Laczek JT, Polish RD, Fraser SL. Two cases of Klebsiella pneumoniae primary liver abscesses; an emerging clinical entity among diabetics. Hawaii Med J 2005; 64:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/52\">",
"      Braiteh F, Golden MP. Cryptogenic invasive Klebsiella pneumoniae liver abscess syndrome. Int J Infect Dis 2007; 11:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/53\">",
"      Gomez C, Broseta A, Otero JR, et al. Primary pyogenic liver abscess cause by magA+ Klebsiella pneumoniae in Spain. Clin Microbiol Newsl 2007; 29:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/54\">",
"      Yu WL, Ko WC, Cheng KC, et al. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 2008; 62:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/55\">",
"      Lin JC, Siu LK, Fung CP, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 2006; 91:3084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/56\">",
"      Yu WL, Chan KS, Ko WC, et al. Lower prevalence of diabetes mellitus in patients with Klebsiella pneumoniae primary liver abscess caused by isolates of K1/K2 than with non-K1/K2 capsular serotypes. Clin Infect Dis 2007; 45:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/57\">",
"      Tom&aacute;s JM, Bened&iacute; VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/58\">",
"      McCallum KL, Laakso DH, Whitfield C. Use of a bacteriophage-encoded glycanase enzyme in the generation of lipopolysaccharide O side chain deficient mutants of Escherichia coli O9:K30 and Klebsiella O1:K20: role of O and K antigens in resistance to complement-mediated serum killing. Can J Microbiol 1989; 35:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/59\">",
"      Albert&iacute; S, Marqu&eacute;s G, Camprub&iacute; S, et al. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 1993; 61:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/60\">",
"      Albert&iacute; S, Alvarez D, Merino S, et al. Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae. Infect Immun 1996; 64:4726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/61\">",
"      Shankar-Sinha S, Valencia GA, Janes BK, et al. The Klebsiella pneumoniae O antigen contributes to bacteremia and lethality during murine pneumonia. Infect Immun 2004; 72:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/62\">",
"      Miles AA, Khimji PL. Enterobacterial chelators of iron: their occurrence, detection, and relation to pathogenicity. J Med Microbiol 1975; 8:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/63\">",
"      Lodge JM, Williams P, Brown MR. Influence of growth rate and iron limitation on the expression of outer membrane proteins and enterobactin by Klebsiella pneumoniae grown in continuous culture. J Bacteriol 1986; 165:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/64\">",
"      Nassif X, Sansonetti PJ. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infect Immun 1986; 54:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/65\">",
"      Williams P, Smith MA, Stevenson P, et al. Novel aerobactin receptor in Klebsiella pneumoniae. J Gen Microbiol 1989; 135:3173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/66\">",
"      Podschun R, Sievers D, Fischer A, Ullmann U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 1993; 168:1415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/67\">",
"      Podschun R, Fischer A, Ullmann U. Siderophore production of Klebsiella species isolated from different sources. Zentralbl Bakteriol 1992; 276:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/68\">",
"      Tarkkanen AM, Allen BL, Williams PH, et al. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 1992; 60:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/69\">",
"      Vernet V, Philippon A, Madoulet C, et al. Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumoniae and Escherichia coli blood culture isolates. FEMS Microbiol Lett 1995; 130:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/70\">",
"      Gerlach GF, Clegg S, Allen BL. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 1989; 171:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/71\">",
"      Jones CH, Pinkner JS, Roth R, et al. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A 1995; 92:2081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/72\">",
"      Sebghati TA, Korhonen TK, Hornick DB, Clegg S. Characterization of the type 3 fimbrial adhesins of Klebsiella strains. Infect Immun 1998; 66:2887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/73\">",
"      Jagnow J, Clegg S. Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces. Microbiology 2003; 149:2397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/74\">",
"      Langstraat J, Bohse M, Clegg S. Type 3 fimbrial shaft (MrkA) of Klebsiella pneumoniae, but not the fimbrial adhesin (MrkD), facilitates biofilm formation. Infect Immun 2001; 69:5805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/75\">",
"      Di Martino P, Livrelli V, Sirot D, et al. A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 1996; 64:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/76\">",
"      Vernet V, Madoulet C, Chippaux C, Philippon A. Incidence of two virulence factors (aerobactin and mucoid phenotype) among 190 clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamase. FEMS Microbiol Lett 1992; 75:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/77\">",
"      Lin TL, Tang SI, Fang CT, et al. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: recharacterization of shv-27, shv-41, and tem-116. Microb Drug Resist 2006; 12:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/78\">",
"      Chan KS, Yu WL, Tsai CL, et al. Pyogenic liver abscess caused by Klebsiella pneumoniae: analysis of the clinical characteristics and outcomes of 84 patients. Chin Med J (Engl) 2007; 120:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21801/abstract/79\">",
"      Sahly H, Aucken H, Bened&iacute; VJ, et al. Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2004; 48:3477.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3125 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-09444732DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21801=[""].join("\n");
var outline_f21_18_21801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H43831948\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Capsular serotypes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypermucoviscosity phenotype",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - RmpA gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - MagA gene",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Relationship between magA and rmpA",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Primary liver abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Lipopolysaccharide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Siderophores",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pili (fimbriae)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Virulence of ESBL-producing strains",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43831948\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3125\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3125|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/43/38576\" title=\"picture 1\">",
"      Mucoid phenotype K pneu",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3125|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/21/32091\" title=\"table 1\">",
"      Virulence factors K pneum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/58/10156\" title=\"table 2\">",
"      Degree of virulence K pneum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38426?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Klebsiella pneumoniae infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/31/29176?source=related_link\">",
"      Invasive liver abscess syndrome caused by Klebsiella pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5449?source=related_link\">",
"      Pathophysiology of sepsis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_18_21802="Cutaneous manifestations of internal malignancy";
var content_f21_18_21802=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cutaneous manifestations of internal malignancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Cindy Owen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/18/21802/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/18/21802/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cutaneous manifestations of internal malignancy include nonmalignant skin disorders that occur in association with malignancy (paraneoplastic dermatoses) and skin lesions that represent infiltration of malignant cells into the skin due to metastatic or locoregional spread of disease or the deposition of circulating tumor cells (eg, leukemia cutis). A wide variety of paraneoplastic dermatoses have been described, including proliferative, inflammatory, bullous, and other types of skin disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. When paraneoplastic dermatoses develop before an internal neoplasm is recognized, recognition of these disorders can aid in the diagnosis of the malignancy.",
"   </p>",
"   <p>",
"    Curth&rsquo;s postulates, a set of diagnostic criteria, have been used by some authors to determine whether a cutaneous disorder should be classified as a paraneoplastic dermatosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/1\">",
"     1",
"    </a>",
"    ]. Curth&rsquo;s postulates are provided in a table (",
"    <a class=\"graphic graphic_table graphicRef71642 \" href=\"UTD.htm?12/50/13099\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The most common paraneoplastic dermatoses will be discussed here; a discussion of disorders that represent tumoral infiltration of the skin is beyond the scope of this topic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/14?source=see_link\">",
"     \"Paget disease of the breast\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/58/20393?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Staging and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DERMATOSES DUE TO METABOLIC PRODUCTS OF MALIGNANCY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hyperpigmentation in ectopic Cushing's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ectopic Cushing's syndrome is the most common hormonally-induced paraneoplastic syndrome associated with internal malignancy. The syndrome is characterized by generalized hyperpigmentation (cutaneous and mucosal), muscle wasting, proximal muscle weakness, hypokalemic metabolic alkalosis, abnormal glucose tolerance, and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=see_link\">",
"     \"Epidemiology and clinical manifestations of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ectopic Cushing&rsquo;s syndrome is caused by hypersecretion of proopiomelanocortin (POMC) from tumors outside of the pituitary gland. POMC is a prohormone of melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH). Both MSH and ACTH are capable of stimulating melanin synthesis, which leads to the development of hyperpigmentation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=see_link\">",
"     \"Causes and pathophysiology of Cushing's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common cause of ectopic Cushing's syndrome is lung carcinoma, specifically the small cell neuroendocrine type. Cushing&rsquo;s syndrome is less frequently associated with carcinoid tumors, thymomas, and pheochromocytomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=see_link\">",
"     \"Pathobiology and staging of small cell carcinoma of the lung\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8474?source=see_link\">",
"     \"Clinical presentation and management of thymoma and thymic carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In Cushing&rsquo;s syndrome, the normal diurnal variation in cortisol production is absent, and most patients do not respond normally to the 48-hour",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    suppression test. Surgical removal of the ACTH-producing tumor is the treatment of choice, but in the case of small cell lung cancer, chemotherapy is more often considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31225?source=see_link\">",
"     \"Establishing the cause of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1016?source=see_link\">",
"     \"Overview of the treatment of Cushing's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Necrolytic migratory erythema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrolytic migratory erythema (NME) is a transient, weeping eczematous or psoriasiform eruption that occurs in about 70 percent of patients with glucagon-secreting pancreatic islet cell tumors (glucagonomas). Lesions primarily occur around body orifices, in skin flexures, and in acral sites (",
"    <a class=\"graphic graphic_picture graphicRef76162 graphicRef56367 graphicRef73263 \" href=\"UTD.htm?39/5/40026\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/5\">",
"     5",
"    </a>",
"    ]. Anemia, weight loss, stomatitis, abdominal pain, diarrhea, and thromboembolic phenomena are additional common features. The diagnosis of NME is indicated by the presence of characteristic clinical features, an elevated serum glucagon level, and radiographic or histologic evidence of a glucagon-secreting pancreatic tumor.",
"   </p>",
"   <p>",
"    Although NME has been described as pathognomonic for glucagonoma, some patients with this condition do not have glucagon-producing tumors. These patients are categorized as having pseudoglucagonoma syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/6\">",
"     6",
"    </a>",
"    ]. Examples of other disorders that have been associated with NME include celiac disease, cirrhosis of the liver, and inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/7\">",
"     7",
"    </a>",
"    ]. Various extrapancreatic malignancies, such as hepatocellular, lung, and duodenal cancer, and tumors that secret insulin or insulin-like growth factor II also have been linked to NME.",
"   </p>",
"   <p>",
"    Any patient with an unusual, transient, recurrent perioral eruption who is systemically ill should undergo evaluation for a pancreatic tumor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31640?source=see_link&amp;anchor=H9#H9\">",
"     \"Glucagonoma and the glucagonoma syndrome\", section on 'Diagnosis, localization, and staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    controls NME effectively, but does not appear to affect the underlying malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/8\">",
"     8",
"    </a>",
"    ]. Surgical removal of the tumor, when feasible, can result in the resolution of NME [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/5,9\">",
"     5,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31640?source=see_link&amp;anchor=H17#H17\">",
"     \"Glucagonoma and the glucagonoma syndrome\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pancreatic panniculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic panniculitis, a form of lobular panniculitis, is a rare condition in which necrosis of fat within the panniculus and other distant foci occurs in the setting of chronic pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/10\">",
"     10",
"    </a>",
"    ]. Pancreatic panniculitis also has occurred in patients with acinar and islet cell pancreatic cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/10-15\">",
"     10-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/27/44472?source=see_link\">",
"     \"Pathology of exocrine pancreatic neoplasms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17112?source=see_link&amp;anchor=H2492460#H2492460\">",
"     \"Panniculitis: Recognition and diagnosis\", section on 'Enzymatic destruction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tender erythematous to violaceous, ulcerated nodules can occur anywhere on the body and are attributed to the massive release of lipolytic enzymes into the bloodstream [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/10,12,15\">",
"     10,12,15",
"    </a>",
"    ]. Patients are systemically ill with fever and weight loss, and joint manifestations may be prominent. Serum lipase and amylase levels are elevated. In cases associated with a pancreatic neoplasm, the tumor is usually advanced by the time cutaneous lesions appear. Nevertheless, treatment may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Amyloidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amyloidosis refers to the extracellular tissue deposition of fibrils composed of low molecular weight subunits (5 to 25 kD) of a variety of low molecular weight serum proteins. In primary (AL) amyloidosis, fragments of monoclonal light chains with or without heavy chains are deposited in the kidney and other tissues, including the skin.",
"   </p>",
"   <p>",
"    The most common mucocutaneous findings in amyloidosis are purpura, petechiae, and ecchymoses following minor trauma (&ldquo;pinch purpura&rdquo;) (",
"    <a class=\"graphic graphic_picture graphicRef77887 \" href=\"UTD.htm?8/49/8984\">",
"     picture 2",
"    </a>",
"    ). A classic finding is the appearance of periorbital purpura following a Valsalva maneuver or dependent positioning of the head. Macroglossia (",
"    <a class=\"graphic graphic_picture graphicRef65060 \" href=\"UTD.htm?6/60/7107\">",
"     picture 3",
"    </a>",
"    ), waxy papules and plaques, enlarged shoulder pads, bullous lesions, and sclerodermatous changes in the skin may also be seen.",
"   </p>",
"   <p>",
"    AL amyloidosis can occur alone or in association with plasma cell dyscrasias such as multiple myeloma, and less frequently, Waldenstrom's macroglobulinemia. Testing with immunofixation electrophoresis is preferred over the serum protein electrophoresis in these patients as some patients go undetected with SPEP. Patients who are found to have smoldering (asymptomatic) multiple myeloma require periodic follow-up for progression to overt disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=see_link\">",
"     \"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/60/4041?source=see_link&amp;anchor=H22391006#H22391006\">",
"     \"Clinical course and management of monoclonal gammopathy of undetermined significance\", section on 'Disease progression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Generalized dermal melanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, generalized melanosis with a diffuse slate-gray color to the skin may develop in a patient with extensive metastatic melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Since malignant melanocytes are rarely detected in involved areas, pigmentation is thought to be due to dissemination of melanin pigment with uptake by dermal macrophages [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/19\">",
"     19",
"    </a>",
"    ]. Aberrant production of melanocyte growth factors may contribute to this phenomenon [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/17,20\">",
"     17,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PARANEOPLASTIC PROLIFERATIVE DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Acanthosis nigricans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acanthosis (\"acantho\" meaning \"thorn\") nigricans (black) is a reactive skin pattern that typically presents as velvety hyperpigmented plaques in intertriginous areas (",
"    <a class=\"graphic graphic_picture graphicRef64585 graphicRef66384 graphicRef81693 \" href=\"UTD.htm?35/39/36474\">",
"     picture 4A-C",
"    </a>",
"    ). While the majority of cases of acanthosis nigricans are benign and associated with obesity and insulin resistance, the disease also can herald the onset of malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27897?source=see_link\">",
"     \"Acanthosis nigricans\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acanthosis nigricans has been reported in association with malignancy. Gastric cancers are the most common cause of malignant acanthosis nigricans; other cancers that have been reported in association with this disorder include hepatocellular carcinoma and adenocarcinomas of the lung, ovary, endometrium, kidneys, pancreas, bladder, breast, and other sites [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/2,21-26\">",
"     2,21-26",
"    </a>",
"    ]. In one study of 227 patients with internal malignancy-associated acanthosis nigricans, gastric adenocarcinoma was the underlying malignancy in 55 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/27\">",
"     27",
"    </a>",
"    ]. Most commonly, the skin manifestations accompany the malignancy, but they can precede or follow the diagnosis of cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=see_link\">",
"     \"Clinical features and diagnosis of primary hepatocellular carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual clinical features and biopsy findings of acanthosis nigricans are discussed elsewhere (",
"    <a class=\"graphic graphic_picture graphicRef64585 graphicRef66384 graphicRef81693 \" href=\"UTD.htm?35/39/36474\">",
"     picture 4A-C",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27897?source=see_link\">",
"     \"Acanthosis nigricans\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compared with patients with obesity or insulin resistance, malignancy-associated acanthosis nigricans typically has a more striking clinical presentation. Patients tend to be older, are generally not obese, and have often experienced recent unintentional weight loss leading to a cachectic appearance. Cutaneous lesions are florid and may develop in unusual locations or in combination with the sudden appearance of multiple skin tags and eruptive seborrheic keratoses (ie, the sign of Leser-Trelat) (see",
"    <a class=\"local\" href=\"#H3208461\">",
"     'Sign of Leser-Trelat'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. In addition, acanthosis nigricans can occur in conjunction with tripe palms (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Tripe palm'",
"    </a>",
"    below). The suspicion for malignancy should increase in patients with extensive or rapidly progressive lesions, when there is mucous membrane involvement, or when prominent sole and palm disease is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient presenting with acanthosis nigricans, key features of the medical history are the age of onset, family history, signs or symptoms of hyperinsulinemia and hyperandrogenism, use of new medications (eg, nicotinic acid, diethylstilbestrol, oral contraceptives, and systemic glucocorticoids), and signs or symptoms suspicious for malignancy. Since the most common cause of acanthosis nigricans is obesity-associated insulin resistance, an appropriate initial laboratory panel includes fasting glucose and insulin levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27897?source=see_link\">",
"     \"Acanthosis nigricans\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If there is no family history, insulin resistance has been ruled out, and medications are considered unlikely, an underlying malignancy should be suspected. In such patients, screening tests for common gastrointestinal cancers could be considered, based upon smoking history, patient age, and signs or symptoms, particularly unexplained anemia suggestive of occult gastrointestinal blood loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy-associated acanthosis nigricans is best treated by definitive treatment of the underlying malignancy, which can lead to resolution of the skin condition [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208461\">",
"    <span class=\"h2\">",
"     Sign of Leser-Trelat",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sign of Leser-Trelat, the explosive onset of multiple pruritic seborrheic keratoses, often with an inflammatory base, can be an ominous sign of internal malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/30,32-34\">",
"     30,32-34",
"    </a>",
"    ]. In addition, seborrheic keratoses may increase in size or become inflamed and symptomatic. Patients with Leser-Trelat also may have accompanying acanthosis nigricans. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Acanthosis nigricans'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/553?source=see_link&amp;anchor=H1101421989#H1101421989\">",
"     \"Overview of benign lesions of the skin\", section on 'Seborrheic keratosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although most associated neoplasms are gastrointestinal adenocarcinomas (stomach, liver, colorectal, and pancreas), breast and lung cancers, and lymphoid malignancies are occasionally discovered [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/32\">",
"     32",
"    </a>",
"    ]. It is likely that various cytokines and other growth factors produced by the neoplasm are responsible for the abrupt appearance of the seborrheic keratoses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Palmar hyperkeratosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Keratoderma of the palms and soles (also known as tylosis) presents as a yellow, symmetrical, smooth bilateral thickening of the epidermis (",
"    <a class=\"graphic graphic_picture graphicRef74683 \" href=\"UTD.htm?25/42/26272\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/35\">",
"     35",
"    </a>",
"    ]. The inherited type of tylosis (Howell-Evans syndrome) has been most strongly associated with squamous cell carcinoma of the esophagus. However, sporadic cases of tylosis have also been associated with Hodgkin lymphoma, leukemia, and breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/32,36\">",
"     32,36",
"    </a>",
"    ]. This condition needs to be distinguished from the T-cell malignancy mycosis fungoides localized to the palms and soles [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32250?source=see_link&amp;anchor=H2#H2\">",
"     \"Epidemiology, pathobiology, and clinical manifestations of esophageal cancer\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Tripe palm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tripe palm refers to a characteristic velvety thickening of the palms with a ridged or rugose appearance (",
"    <a class=\"graphic graphic_picture graphicRef61955 \" href=\"UTD.htm?14/59/15283\">",
"     picture 6",
"    </a>",
"    ). The term is derived from its resemblance to the stomach mucosa of ruminants (tripe).",
"   </p>",
"   <p>",
"    Tripe palm is predominantly associated with gastric or bronchogenic cancer, although it has been rarely described in association with a variety of other malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. In one review, 94 percent of cases were associated with malignancy, and it was the initial presenting feature of a previously undiagnosed malignancy in 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/39\">",
"     39",
"    </a>",
"    ]. Three-fourths of cases presented with concurrent acanthosis nigricans. Bronchogenic carcinoma accounted for 53 percent of cases with tripe palm only, while both gastric adenocarcinoma (35 percent) and pulmonary carcinoma (11 percent) were found in those with both tripe palm and acanthosis nigricans.",
"   </p>",
"   <p>",
"    In view of the strong association of tripe palm with malignancy, a full cancer screening examination, with particular attention to the lungs and gastrointestinal tract, should be performed in adults with this condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Bazex's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bazex's syndrome (acrokeratosis paraneoplastica) is a rare paraneoplastic phenomenon that is strongly associated with squamous cell carcinoma of the upper aerodigestive tract, but it has also been reported with a number of other tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/40-44\">",
"     40-44",
"    </a>",
"    ]. Patients present with erythematous to violaceous psoriasiform plaques predominantly located in acral areas (",
"    <a class=\"graphic graphic_picture graphicRef66781 graphicRef66625 graphicRef79717 \" href=\"UTD.htm?31/37/32346\">",
"     picture 7A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/45\">",
"     45",
"    </a>",
"    ]. Nail dystrophy, palmoplantar keratoderma, and alopecia are common.",
"   </p>",
"   <p>",
"    Treatment of the neoplasm usually leads to resolution of the cutaneous lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/41\">",
"     41",
"    </a>",
"    ], but there are reports of patients whose lesions persist following successful tumor therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208716\">",
"    <span class=\"h2\">",
"     Hypertrophic osteoarthropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The triad of hypertrophic osteoarthropathy (also known as pachydermoperiostosis) includes new periosteal bone formation in the radius, phalanges, or tibia (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57502 graphicRef70330 \" href=\"UTD.htm?32/3/32816\">",
"     image 1A-B",
"    </a>",
"    ), thickening of the skin in prominent folds and creases (especially notable on the scalp [cutis verticis gyrata] and forehead), and clubbing of the fingers (",
"    <a class=\"graphic graphic_picture graphicRef80452 graphicRef61526 \" href=\"UTD.htm?32/46/33511\">",
"     picture 8A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef52839 \" href=\"UTD.htm?42/58/43951\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The acquired form of hypertrophic osteoarthropathy can be due to chronic pulmonary or cardiac conditions producing peripheral hypoxia. There is also an association with lung cancer, primarily non-small cell lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35496?source=see_link&amp;anchor=H13#H13\">",
"     \"Malignancy and rheumatic disorders\", section on 'Hypertrophic osteoarthropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208324\">",
"    <span class=\"h1\">",
"     PARANEOPLASTIC INFLAMMATORY DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208878\">",
"    <span class=\"h2\">",
"     Sweet syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sweet syndrome (acute febrile neutrophilic dermatosis) consists of a cutaneous eruption characterized by a dermal nonvasculitic neutrophilic infiltration, fever, and peripheral neutrophilia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/48\">",
"     48",
"    </a>",
"    ]. It is associated with a variety of underlying diseases in up to 50 percent of patients.",
"   </p>",
"   <p>",
"    Approximately 10 percent of patients with Sweet syndrome have an underlying malignancy or premalignant process, most commonly myelogenous leukemia or a myelogenous pre-leukemic state. Occurrences with solid tumors, lymphomas, and plasma cell dyscrasias also have been reported. Sweet syndrome is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40905?source=see_link\">",
"     \"Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cutaneous eruption consists of tender, well-demarcated erythematous to violaceous papules and plaques with an irregular pseudovesiculated surface (",
"    <a class=\"graphic graphic_picture graphicRef79243 graphicRef74393 \" href=\"UTD.htm?17/58/18344\">",
"     picture 9A-B",
"    </a>",
"    ). The plaques may have a central yellowish discoloration, creating a targetoid appearance, and pustulation and blistering can occur. The plaques may cause pain and a burning sensation, but usually are not pruritic.",
"   </p>",
"   <p>",
"    Lesions are most often found on the face, neck, and upper extremities, especially the dorsum of hands, but can occur anywhere. Oral lesions, which develop in 3 to 30 percent of patients, may be initially pseudovesicular and may ulcerate later. On the lower extremities, the lesions can resemble erythema nodosum (",
"    <a class=\"graphic graphic_picture graphicRef63142 \" href=\"UTD.htm?40/52/41806\">",
"     picture 10",
"    </a>",
"    ). Fever, leukocytosis, arthralgias, and episcleritis accompany the skin lesions. Infection must be ruled out in all cases.",
"   </p>",
"   <p>",
"    The standard and most effective therapy is a course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    for two to four weeks. Even those cases associated with malignancy respond rapidly to this regimen. However, lesions may recur upon discontinuation of prednisone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40905?source=see_link\">",
"     \"Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3209272\">",
"    <span class=\"h2\">",
"     Dermatomyositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatomyositis is a condition that presents with numerous cutaneous findings and an associated inflammatory myopathy. The skin findings of dermatomyositis include scaly violaceous papules overlying the bony prominences of the hands (Gottron&rsquo;s papules), violaceous patches on the periorbital skin (heliotrope eruption), photodistributed poikilodermatous patches and plaques, scaly plaques on the scalp and lateral thighs, periungual telangiectasia, and ragged cuticles (",
"    <a class=\"graphic graphic_picture graphicRef63383 graphicRef56879 graphicRef68649 graphicRef54230 graphicRef59545 \" href=\"UTD.htm?40/23/41338\">",
"     picture 11A-E",
"    </a>",
"    ). The myopathy usually presents with a progressive, symmetric, proximal weakness.",
"   </p>",
"   <p>",
"    The malignancies associated with DM include a wide range of tumor types. Ovarian, breast, uterine, lung, gastric, colorectal, and pancreatic cancers are frequently reported. Associated malignancies are usually detected within three years of diagnosis, and the majority are detected within one year. The diagnostic workup and follow-up for malignancy in patients with dermatomyositis is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38566?source=see_link\">",
"     \"Malignancy in dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Erythroderma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythroderma or exfoliative erythroderma syndrome is defined as a diffuse and generalized erythema of the skin that may involve over 90 percent of the body surface area. Severe pruritus, ectropion, and generalized lymphadenopathy are not uncommon, and desquamation usually ensues.",
"   </p>",
"   <p>",
"    The most common cause of erythroderma is a preexisting skin disease, such as atopic dermatitis or psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/49\">",
"     49",
"    </a>",
"    ], followed by drug hypersensitivity reactions. Most cases of paraneoplastic erythroderma are associated with lymphoid malignancies, particularly cutaneous T-cell lymphoma. Follow-up studies of patients originally classified as having \"idiopathic\" erythroderma have shown that a minority (10 to 20 percent in most series) will go on to develop cutaneous T-cell lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/50\">",
"     50",
"    </a>",
"    ]. The term S&eacute;zary syndrome has been used to describe the erythrodermic form of cutaneous T-cell lymphoma (",
"    <a class=\"graphic graphic_picture graphicRef72524 \" href=\"UTD.htm?11/42/11939\">",
"     picture 12",
"    </a>",
"    ); however, newer classification schemes reserve this term for the leukemic phase of erythrodermic cutaneous T-cell lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/17/41241?source=see_link\">",
"     \"Drug eruptions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less commonly, acute myeloid leukemia and solid tumors (lung, prostate, thyroid liver, ovaries, rectum, skin) are associated with paraneoplastic erythroderma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/52\">",
"     52",
"    </a>",
"    ]. Paraneoplastic dermatomyositis may also be initially confused with diffuse erythroderma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38566?source=see_link\">",
"     \"Malignancy in dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic workup of an erythrodermic patient should involve a detailed history and physical examination, with special attention to preexisting skin conditions and both over the counter and prescription drugs. Usually, the erythroderma associated with a preexisting skin condition has a slower onset than the drug-induced or malignancy-associated type. Biopsy, particularly of a primary lesion, may be helpful; however, not uncommonly, histology is nonspecific. Routine laboratory studies and lymph node biopsies are not particularly helpful. A S&eacute;zary prep and peripheral T-cell receptor analysis can be performed if the diagnosis of cutaneous T-cell lymphoma is suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of erythroderma involves stringent attention to hydration and nutrition. Emollients and topical steroids are commonly used to rebuild the skin barrier and decrease inflammation. Further treatment should be directed at the underlying cause, if it can be determined and treated successfully. Because high-output cardiac failure can occur, supportive care is crucial in patients who develop this condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208263\">",
"    <span class=\"h2\">",
"     Erythema gyratum repens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythema gyratum repens is characterized by concentric rings of rapidly migrating erythematous plaques covering a large percentage of the body surface (",
"    <a class=\"graphic graphic_picture graphicRef57355 graphicRef58124 graphicRef68112 \" href=\"UTD.htm?17/4/17481\">",
"     picture 13A-C",
"    </a>",
"    ). A trailing collarette of scale is evident, and lesions are moderately to severely pruritic. In the vast majority of cases (80 percent), there is an associated internal malignancy, most often a bronchogenic carcinoma, less commonly esophageal or breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. The cutaneous eruption may precede, occur with, or follow the diagnosis of malignancy. Improvement often correlates with successful treatment of the underlying cancer.",
"   </p>",
"   <p>",
"    Erythema gyratum repens has also been reported in the setting of benign conditions, such as pulmonary tuberculosis, psoriasis pityriasis rubra pilaris, and autoimmune disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy-associated vasculitis is rare and occurs more often with hematologic malignancies than with solid malignancies. The associated hematologic malignancies are typically lymphoproliferative, or less frequently, myelodysplastic. In patients with hematologic malignancies, the most common presentation is a small vessel cutaneous leukocytoclastic vasculitis. Lesions manifest as palpable purpura that are preferentially located in dependent areas [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/57\">",
"     57",
"    </a>",
"    ]. Solid tumors are associated with many types of vasculitis, including polyarteritis nodosa, Henoch-Sch&ouml;nlein purpura (IgA vasculitis), and small vessel vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=see_link&amp;anchor=H16171977#H16171977\">",
"     \"Evaluation of adults with cutaneous lesions of vasculitis\", section on 'Cutaneous findings'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The proportion of patients with vasculitis who harbor an underlying malignancy is not well-characterized, but appears to be small. Workup for underlying malignancy, therefore, should be guided by associated findings on history, physical examination, or basic laboratory tests. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=see_link\">",
"     \"Evaluation of adults with cutaneous lesions of vasculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3208826\">",
"    <span class=\"h1\">",
"     PARANEOPLASTIC BULLOUS DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Paraneoplastic pemphigus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paraneoplastic pemphigus is typically associated with lymphoreticular malignancies or lymphoproliferative disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Castleman's disease, thymoma, and Waldenstrom's macroglobulinemia. The most consistent feature of paraneoplastic pemphigus is a painful stomatitis (",
"    <a class=\"graphic graphic_picture graphicRef59594 \" href=\"UTD.htm?6/26/6562\">",
"     picture 14",
"    </a>",
"    ). Cutaneous lesions can include tense bullae or lesions resembling erythema multiforme or lichen planus. Patients with paraneoplastic pemphigus also are at risk for severe involvement of the airways leading to bronchiolitis obliterans [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of paraneoplastic pemphigus is made by the demonstration of anti-plakin antibodies on indirect immunofluorescence testing of the patient&rsquo;s serum, together with consistent clinical and histopathologic findings. In a patient with suspected paraneoplastic pemphigus, but without known malignancy, a CT scan of the chest, abdomen, and pelvis should be obtained. Paraneoplastic pemphigus is discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18121?source=see_link\">",
"     \"Paraneoplastic pemphigus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2292429\">",
"    <span class=\"h2\">",
"     Anti-epiligrin cicatricial pemphigoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anti-epiligrin cicatricial pemphigoid (AECP) is an autoimmune blistering condition characterized by severe, painful lesions of the oral mucosa and skin lesions consisting of bullae and erosions on an erythematous base. Distinction from other types of cicatricial pemphigoid is important because of an elevated risk for cancer associated with AECP [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/61\">",
"     61",
"    </a>",
"    ]. The types of cancer that occur in patients with AECP vary; most are solid tumors. &nbsp;",
"   </p>",
"   <p>",
"    The diagnosis of AECP is made by demonstration of in situ deposits of IgG autoantibodies on epidermal basement membranes or circulating IgG autoantibodies that bind the dermal side of salt-split skin and immunoprecipitate laminin 5 on radiolabeled human keratinocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/62\">",
"     62",
"    </a>",
"    ]. Nearly all patients have mucosal involvement, and possible severe sequelae include gingival destruction, tooth loss, blindness, dysphagia, dysphonia, and airway compromise. Immunosuppressive therapy may be effective for improving symptoms; however, the disease course often is progressive.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     OTHER PARANEOPLASTIC DERMATOSES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3209055\">",
"    <span class=\"h2\">",
"     Acquired ichthyosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ichthyosis is a generalized scaling of the skin that can be either congenital or acquired. Acquired ichthyosis can be associated with inflammatory, endocrinologic, and neoplastic processes [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/63\">",
"     63",
"    </a>",
"    ]. The presentation of acquired ichthyosis is similar to the inherited condition ichthyosis vulgaris, with prominent fish-like, relatively large scales adherent to the skin; however, the scaling in acquired disease may also be present on the palms and soles and in skin flexures (",
"    <a class=\"graphic graphic_picture graphicRef57819 graphicRef64680 \" href=\"UTD.htm?40/3/41015\">",
"     picture 15A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/7/7285?source=see_link&amp;anchor=H6#H6\">",
"     \"Metabolic and inherited diseases affecting the skin\", section on 'Ichthyosis vulgaris'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hodgkin lymphoma is the most common malignancy associated with acquired ichthyosis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/2,64,65\">",
"     2,64,65",
"    </a>",
"    ]. Less frequently, the underlying cancer is a cutaneous T-cell lymphoma, Kaposi&rsquo;s sarcoma, or a breast, lung, or bladder carcinoma. Isolated cases in the setting of graft versus host disease following allogeneic bone marrow transplantation also have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/66\">",
"     66",
"    </a>",
"    ]. Postulated mechanisms for the development of acquired ichthyosis include the secretion of keratinocyte growth factors by the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/38\">",
"     38",
"    </a>",
"    ] or an autoimmune response directed against the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/66\">",
"     66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25960?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most cases, malignancy-associated acquired ichthyosis is noted after the diagnosis of the underlying malignancy. However, there are a few reports in which recognition of acquired ichthyosis led to the diagnosis of a malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the association of acquired ichthyosis and lymphoma, a physical examination to evaluate for lymphadenopathy and a chest x-ray should be performed in patients diagnosed with acquired ichthyosis. Further evaluation should be performed based upon these results and the clinical suspicion for Hodgkin lymphoma or another underlying malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=see_link\">",
"     \"Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Pruritus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with generalized pruritus who are not jaundiced, a search for systemic diseases should be initiated to rule out iron deficiency, thyroid disease, and hepatic and renal insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/67\">",
"     67",
"    </a>",
"    ]. Malignant neoplasms may also underlie some cases of generalized, refractory pruritus, most commonly lymphoma (particularly Hodgkin lymphoma), multiple myeloma, leukemia, and carcinoid tumor involving the stomach [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/68\">",
"     68",
"    </a>",
"    ]. In contrast to the usually nonpruritic intermittent cutaneous flushing associated with intestinal carcinoid tumors, the intermittent \"histamine\" flush associated with atypical gastric carcinoid tumors tends to be pruritic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"     \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features of the carcinoid syndrome\", section on 'Gastric carcinoid variant syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with generalized pruritus, after a careful history and physical examination, it is reasonable to order a complete blood count, liver function tests, serum chemistries, and thyroid function tests. In refractory cases, a chest x-ray and workup for a paraproteinemia should also be pursued. In the appropriate clinical scenario (intermittent pruritic flushing), a gastric carcinoid should be considered. Therapy should be disease-specific.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hypertrichosis lanuginosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertrichosis lanuginosa (malignant down) refers to the appearance of fine hair growth, which is predominantly localized to the head and neck but may spread to the torso, arms, and legs (",
"    <a class=\"graphic graphic_picture graphicRef70105 \" href=\"UTD.htm?43/17/44319\">",
"     picture 16",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. A strong association of this unusual hair growth has been described with adenocarcinomas arising in the large bowel, breast, lung and kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/32,69\">",
"     32,69",
"    </a>",
"    ]. Removal of the malignancy may lead to resolution of the excess hair growth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=see_link\">",
"     \"Pathogenesis and causes of hirsutism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Xanthomas",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plane xanthomas are yellowish-reddish macules or slightly elevated papules that have a predilection for the head and neck area, and can occur in patients with myeloma (",
"    <a class=\"graphic graphic_picture graphicRef57954 \" href=\"UTD.htm?41/51/42800\">",
"     picture 17",
"    </a>",
"    ). Compared with xanthelasma, plane xanthomas are not as infiltrated and are unusual in the periorbital area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=see_link\">",
"     \"Eyelid lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Palmar crease xanthomas are yellow, often linear macules or papules that follow the creases of the palms and soles. Their significance lies in their relationship to occult hematologic leukocyte malignancy, specifically multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/71\">",
"     71",
"    </a>",
"    ]. It is theorized that the myeloma proteins interfere with lipid metabolism, leading to cutaneous deposition in the palms and soles. A diagnostic workup for myeloma should be considered in patients with this condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Scleromyxedema and scleredema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scleromyxedema and scleredema are rare connective tissue disorders that have been associated with paraproteinemias [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scleromyxedema is characterized by waxy yellow-red papules often arranged in a linear fashion. Lesions occur most commonly on the face, neck, forearms, and hands. When the lesions coalesce, induration similar to sclerodermatous changes may be noted [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/74\">",
"       74",
"      </a>",
"      ]. Associated findings may include sparse eyebrow, axillary, and pubic hair and leonine facies. Middle-aged adults are most commonly affected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43095?source=see_link\">",
"       \"Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adults\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      A monoclonal gammopathy characterized by an IgG lambda paraprotein is commonly detected, but myeloma is rare [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. Treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/54/22376?source=see_link\">",
"       melphalan",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"       thalidomide",
"      </a>",
"      , or high dose intravenous immunoglobulin may reduce the paraprotein, and complete remission has been described following autologous hematopoietic stem cell transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/77-80\">",
"       77-80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Scleredema is characterized by firm, stiff indurated skin on the posterior and lateral portion of the neck and the upper back. The stiffness is caused by increased mucin deposition in the skin. Although scleredema most commonly follows a viral upper respiratory infection or the onset of diabetes mellitus, patients with persistent scleredema often have an associated monoclonal gammopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/81\">",
"       81",
"      </a>",
"      ]. Others have reported the development of myeloma in such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/82,83\">",
"       82,83",
"      </a>",
"      ]. Since cutaneous manifestations can precede the monoclonal gammopathy, immunoelectrophoresis should be performed routinely in patients with scleredema, especially if diffuse. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43095?source=see_link\">",
"       \"Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with suspected scleromyxedema or scleredema, a serum protein electrophoresis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunofixation electrophoresis should be performed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=see_link\">",
"     \"Recognition of monoclonal proteins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3209395\">",
"    <span class=\"h2\">",
"     Multicentric reticulohistiocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multicentric reticulohistiocytosis (MRH) is a rare multisystem disease consisting of a cutaneous histiocytosis and destructive polyarthritis. Flesh-colored to yellow-brown papules and nodules are seen with a predilection for the upper body, and most frequently occur on the face, hands, forearms, and ears. Lesions around the fingernails have a &ldquo;coral bead&rdquo; appearance (",
"    <a class=\"graphic graphic_picture graphicRef77307 \" href=\"UTD.htm?34/17/35090\">",
"     picture 18",
"    </a>",
"    ). In addition, xanthelasma has been noted in one-third of patients with MRH. The arthritis of MRH can be rapidly destructive and progress to arthritis mutilans in half of the patients. Other associated symptoms include fever, weight loss, and weakness.",
"   </p>",
"   <p>",
"    MRH is associated with an underlying malignancy in one quarter of patients. A variety of malignancies have been linked to MRH; breast, hematologic, and gastric cancers are most common [",
"    <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/84\">",
"     84",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11694078\">",
"    <span class=\"h1\">",
"     HERITABLE CONDITIONS ASSOCIATED WITH MALIGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several inherited conditions that predispose to internal malignancy may be associated with cutaneous manifestations. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cowden's syndrome &mdash; Trichilemmomas (adnexal tumors, (",
"      <a class=\"graphic graphic_picture graphicRef60952 \" href=\"UTD.htm?40/31/41459\">",
"       picture 19",
"      </a>",
"      )) with multiple hamartomatous lesions and an increased risk of early onset breast and thyroid cancer. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=see_link&amp;anchor=H462459918#H462459918\">",
"       \"PTEN hamartoma tumor syndrome, including Cowden syndrome\", section on 'Mucocutaneous'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Peutz-Jeghers syndrome &mdash; Multiple hamartomatous polyps in the gastrointestinal tract (with malignant potential) in association with distinctive mucocutaneous pigmentations (",
"      <a class=\"graphic graphic_picture graphicRef55335 \" href=\"UTD.htm?17/16/17666\">",
"       picture 20",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37990?source=see_link\">",
"       \"Overview of Peutz-Jeghers syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Muir-Torre syndrome &mdash; Multiple sebaceous gland and skin tumors, including keratoacanthomas, in conjunction with visceral cancers [",
"      <a class=\"abstract\" href=\"UTD.htm?21/18/21802/abstract/85-87\">",
"       85-87",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link\">",
"       \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Gardner's syndrome &mdash; Desmoid tumors, sebaceous or epidermoid cysts, lipomas, osteomas supernumerary teeth, gastric polyps, juvenile nasopharyngeal angiofibromas and intestinal adenocarcinomas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=see_link\">",
"       \"Gardner syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      von Recklinghausen's disease &mdash; Cutaneous and subcutaneous neurofibromas, caf&eacute;-au-lait macules with optic pathway gliomas and other tumors involving the nervous system. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Examples of other heritable conditions associated with malignancy and prominent cutaneous findings include neurofibromatosis type 1, Birt-Hogg-Dube syndrome and multiple endocrine neoplasia syndromes. In addition, some patients with a strong family history of melanoma have an increased risk for pancreatic cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=see_link&amp;anchor=H4#H4\">",
"     \"Hereditary kidney cancer syndromes\", section on 'Birt-Hogg-Dube syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43240?source=see_link\">",
"     \"Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=see_link&amp;anchor=H9#H9\">",
"     \"Inherited susceptibility to melanoma\", section on 'Pancreatic cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11693911\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A wide variety of cutaneous disorders can occur in the setting of malignancy. Skin conditions that are associated with neoplastic disorders, but do not represent cutaneous infiltration of malignant cells comprise the paraneoplastic dermatoses. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Knowledge of the paraneoplastic dermatoses is of value in the clinical setting. The presence of unexplained cutaneous findings consistent with a paraneoplastic disorder can indicate the need to evaluate a patient for an underlying internal malignancy.",
"     </li>",
"     <li>",
"      The recognition of a paraneoplastic neoplastic dermatosis can be useful for providing a patient with realistic expectations regarding the expected course of his or her skin disease. For some paraneoplastic dermatoses, successful treatment of the underlying malignancy is essential for the resolution of the dermatosis.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/1\">",
"      Thiers BH, Sahn RE, Callen JP. Cutaneous manifestations of internal malignancy. CA Cancer J Clin 2009; 59:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/2\">",
"      Ehst BD, Minzer-Conzetti K, Swerdlin A, Devere TS. Cutaneous manifestations of internal malignancy. Curr Probl Surg 2010; 47:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/3\">",
"      Pivonello R, De Martino MC, De Leo M, et al. Cushing's Syndrome. Endocrinol Metab Clin North Am 2008; 37:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/4\">",
"      Wakamatsu K, Graham A, Cook D, Thody AJ. Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor. Pigment Cell Res 1997; 10:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/5\">",
"      Lobo I, Carvalho A, Amaral C, et al. Glucagonoma syndrome and necrolytic migratory erythema. Int J Dermatol 2010; 49:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/6\">",
"      Marinkovich MP, Botella R, Datloff J, Sangueza OP. Necrolytic migratory erythema without glucagonoma in patients with liver disease. J Am Acad Dermatol 1995; 32:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/7\">",
"      Tierney EP, Badger J. Etiology and pathogenesis of necrolytic migratory erythema: review of the literature. MedGenMed 2004; 6:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/8\">",
"      Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001; 321:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/9\">",
"      Remes-Troche JM, Garc&iacute;a-de-Acevedo B, Zu&ntilde;iga-Varga J, et al. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome. J Eur Acad Dermatol Venereol 2004; 18:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/10\">",
"      Garc&iacute;a-Romero D, Vanaclocha F. Pancreatic panniculitis. Dermatol Clin 2008; 26:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/11\">",
"      Bennett RG, Petrozzi JW. Nodular subcutaneous fat necrosis. A manifestation of silent pancreatitis. Arch Dermatol 1975; 111:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/12\">",
"      Heykarts B, Anseeuw M, Degreef H. Panniculitis caused by acinous pancreatic carcinoma. Dermatology 1999; 198:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/13\">",
"      Dahl PR, Su WP, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Dermatol 1995; 33:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/14\">",
"      Lewis CT 3rd, Tschen JA, Klima M. Subcutaneous fat necrosis associated with pancreatic islet cell carcinoma. Am J Dermatopathol 1991; 13:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/15\">",
"      van Klaveren RJ, de Mulder PH, Boerbooms AM, et al. Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity. Gut 1990; 31:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/16\">",
"      Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010; 24:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/17\">",
"      B&ouml;hm M, Schiller M, Nashan D, et al. Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors. J Am Acad Dermatol 2001; 44:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/18\">",
"      Murray C, D'Intino Y, MacCormick R, et al. Melanosis in association with metastatic malignant melanoma: report of a case and a unifying concept of pathogenesis. Am J Dermatopathol 1999; 21:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/19\">",
"      Spremulli EN, Bogaars HA, Dexter DL, et al. Nude mouse model of the melanosis syndrome. J Natl Cancer Inst 1983; 71:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/20\">",
"      Steiner A, Rappersberger K, Groh V, Pehamberger H. Diffuse melanosis in metastatic malignant melanoma. J Am Acad Dermatol 1991; 24:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/21\">",
"      Krawczyk M, Mykaa-Ciela J, Koodziej-Jaskua A. Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Pol Arch Med Wewn 2009; 119:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/22\">",
"      Kamiska-Winciorek G, Brzeziska-Wciso L, Lis-Swiety A, Krauze E. Paraneoplastic type of acanthosis nigricans in patient with hepatocellular carcinoma. Adv Med Sci 2007; 52:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/23\">",
"      Serap D, Ozlem S, Melike Y, et al. Acanthosis nigricans in a patient with lung cancer: a case report. Case Report Med 2010; 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/24\">",
"      Oh CW, Yoon J, Kim CY. Malignant Acanthosis Nigricans Associated with Ovarian Cancer. Case Rep Dermatol 2010; 2:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/25\">",
"      Longshore SJ, Taylor JS, Kennedy A, Nurko S. Malignant acanthosis nigricans and endometrioid adenocarcinoma of the parametrium: the search for malignancy. J Am Acad Dermatol 2003; 49:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/26\">",
"      Moscardi JL, Macedo NA, Espasandin JA, Pi&ntilde;eyro MI. Malignant acanthosis nigricans associated with a renal tumor. Int J Dermatol 1993; 32:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/27\">",
"      Rigel DS, Jacobs MI. Malignant acanthosis nigricans: a review. J Dermatol Surg Oncol 1980; 6:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/28\">",
"      Brown J, Winkelmann RK. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968; 47:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/29\">",
"      Yeh JS, Munn SE, Plunkett TA, et al. Coexistence of acanthosis nigricans and the sign of Leser-Tr&eacute;lat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol 2000; 42:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/30\">",
"      Heaphy MR Jr, Millns JL, Schroeter AL. The sign of Leser-Tr&eacute;lat in a case of adenocarcinoma of the lung. J Am Acad Dermatol 2000; 43:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/31\">",
"      Ellis DL, Kafka SP, Chow JC, et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Tr&eacute;lat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987; 317:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/32\">",
"      Kurzrock R, Cohen PR. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 1995; 99:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/33\">",
"      Schwartz RA. Sign of Leser-Tr&eacute;lat. J Am Acad Dermatol 1996; 35:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/34\">",
"      Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J Am Acad Dermatol 1992; 26:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/35\">",
"      Ratnavel RC, Griffiths WA. The inherited palmoplantar keratodermas. Br J Dermatol 1997; 137:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/36\">",
"      Itin PH, Lautenschlager S. Palmoplantar keratoderma and associated syndromes. Semin Dermatol 1995; 14:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/37\">",
"      Kim ST, Jeon YS, Sim HJ, et al. Clinicopathologic features and T-cell receptor gene rearrangement findings of mycosis fungoides palmaris et plantaris. J Am Acad Dermatol 2006; 54:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/38\">",
"      Ameen M, Chopra S, Darvay A, et al. Erythema gyratum repens and acquired ichthyosis associated with transitional cell carcinoma of the kidney. Clin Exp Dermatol 2001; 26:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/39\">",
"      Cohen PR, Grossman ME, Almeida L, Kurzrock R. Tripe palms and malignancy. J Clin Oncol 1989; 7:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/40\">",
"      Richard M, Giroux JM. Acrokeratosis paraneoplastica (Bazex' syndrome). J Am Acad Dermatol 1987; 16:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/41\">",
"      Lucker GP, Steijlen PM. Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin's disease. Br J Dermatol 1995; 133:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/42\">",
"      Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991; 70:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/43\">",
"      Sator PG, Breier F, Gschnait F. Acrokeratosis paraneoplastica (Bazex's syndrome): association with liposarcoma. J Am Acad Dermatol 2006; 55:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/44\">",
"      Taher M, Grewal P, Gunn B, et al. Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zinc. J Cutan Med Surg 2007; 11:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/45\">",
"      Bolognia JL. Bazex syndrome: acrokeratosis paraneoplastica. Semin Dermatol 1995; 14:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/46\">",
"      Fasanmade A, Farrell K, Perkins CS. Bazex syndrome (acrokeratosis paraneoplastica): persistence of cutaneous lesions after successful treatment of an associated oropharyngeal neoplasm. Br J Oral Maxillofac Surg 2009; 47:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/47\">",
"      Sridhar KS, Lobo CF, Altman RD. Digital clubbing and lung cancer. Chest 1998; 114:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/48\">",
"      Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 2003; 42:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/49\">",
"      Nicolis GD, Helwig EB. Exfoliative dermatitis. A clinicopathologic study of 135 cases. Arch Dermatol 1973; 108:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/50\">",
"      Sigurdsson V, Toonstra J, van Vloten WA. Idiopathic erythroderma: a follow-up study of 28 patients. Dermatology 1997; 194:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/51\">",
"      Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002; 46:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/52\">",
"      King LE Jr, Dufresne RG Jr, Lovett GL, Rosin MA. Erythroderma: review of 82 cases. South Med J 1986; 79:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/53\">",
"      Nousari HC, Kimyai-Asadi A, Spegman DJ. Paraneoplastic dermatomyositis presenting as erythroderma. J Am Acad Dermatol 1998; 39:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/54\">",
"      Appell ML, Ward WQ, Tyring SK. Erythema gyratum repens. A cutaneous marker of malignancy. Cancer 1988; 62:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/55\">",
"      Eubanks LE, McBurney E, Reed R. Erythema gyratum repens. Am J Med Sci 2001; 321:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/56\">",
"      Demonchy E, Lacour JP, Ortonne JP, Passeron T. Erythema gyratum repens, not always a bad omen for patients. J Eur Acad Dermatol Venereol 2010; 24:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/57\">",
"      Wooten MD, Jasin HE. Vasculitis and lymphoproliferative diseases. Semin Arthritis Rheum 1996; 26:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/58\">",
"      Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009. J Am Acad Dermatol 2012; 66:e55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/59\">",
"      Kurzrock R, Cohen PR, Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors. A case report and review of the literature. Arch Intern Med 1994; 154:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/60\">",
"      Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/61\">",
"      Egan CA, Lazarova Z, Darling TN, et al. Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 2001; 357:1850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/62\">",
"      Egan CA, Lazarova Z, Darling TN, et al. Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations. Medicine (Baltimore) 2003; 82:177.",
"     </a>",
"    </li>",
"    <li>",
"     DiGiovanna JJ. Ichthyosiform Dermatoses. In: Fitzpatrick's Dermatology in General Medicine, Freedberg IM, Eisen AZ, Wolff K, et al (Eds), New York, New York New York. p.New York.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/64\">",
"      Riesco Mart&iacute;nez MC, Mu&ntilde;oz Mart&iacute;n AJ, Zamberk Majlis P, et al. Acquired ichthyosis as a paraneoplastic syndrome in Hodgkin's disease. Clin Transl Oncol 2009; 11:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/65\">",
"      Rabhi M, Ennibi K, Harket A, et al. Acquired ichthyosis disclosing non-Hodgkin's malignant lymphoma. Intern Med 2007; 46:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/66\">",
"      Spelman LJ, Strutton GM, Robertson IM, Weedon D. Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 1996; 35:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/67\">",
"      Gilchrest BA. Pruritus: pathogenesis, therapy, and significance in systemic disease states. Arch Intern Med 1982; 142:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/68\">",
"      Paul R, Paul R, Jansen CT. Itch and malignancy prognosis in generalized pruritus: a 6-year follow-up of 125 patients. J Am Acad Dermatol 1987; 16:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/69\">",
"      Vulink AJ, ten Bokkel Huinink D. Acquired hypertrichosis lanuginosa: a rare cutaneous paraneoplastic syndrome. J Clin Oncol 2007; 25:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/70\">",
"      Slee PH, van der Waal RI, Schagen van Leeuwen JH, et al. Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked? Br J Dermatol 2007; 157:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/71\">",
"      Marien KJ, Smeenk G. Plane xanthomata associated with multiple myeloma and hyperlipoproteinaemia. Br J Dermatol 1975; 93:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/72\">",
"      Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 2006; 35:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/73\">",
"      Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol 2006; 24:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/74\">",
"      Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/75\">",
"      Kitamura W, Matsuoka Y, Miyagawa S, Sakamoto K. Immunochemical analysis of the monoclonal paraprotein in scleromyxedema. J Invest Dermatol 1978; 70:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/76\">",
"      Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine (Baltimore) 1988; 67:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/77\">",
"      Lister RK, Jolles S, Whittaker S, et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/78\">",
"      Blum M, Wigley FM, Hummers LK. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) 2008; 87:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/79\">",
"      Donato ML, Feasel AM, Weber DM, et al. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 2006; 107:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/80\">",
"      Sansbury JC, Cocuroccia B, Jorizzo JL, et al. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 2004; 51:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/81\">",
"      K&ouml;vary PM, Vakilzadeh F, Macher E, et al. Monoclonal gammopathy in scleredema. Observations in three cases. Arch Dermatol 1981; 117:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/82\">",
"      Pujol JA, Bueno M, Fuertes MA, et al. Improvement of scleredema associated with IgA multiple myeloma after chemotherapy. Clin Exp Dermatol 1995; 20:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/83\">",
"      Hodak E, Tamir R, David M, et al. Scleredema adultorum associated with IgG-kappa multiple myeloma--a case report and review of the literature. Clin Exp Dermatol 1988; 13:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/84\">",
"      Snow JL, Muller SA. Malignancy-associated multicentric reticulohistiocytosis: a clinical, histological and immunophenotypic study. Br J Dermatol 1995; 133:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/85\">",
"      Cimen S, Aslan G, Lebe B, et al. Penile keratoacanthoma associated with urothelial carcinoma of the bladder in Muir-Torre syndrome. Urol Oncol 2007; 25:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/86\">",
"      Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol 2005; 6:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/18/21802/abstract/87\">",
"      Dores GM, Curtis RE, Toro JR, et al. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer 2008; 113:3372.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7606 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-217.117.136.88-D8E73D39BC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21802=[""].join("\n");
var outline_f21_18_21802=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11693911\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DERMATOSES DUE TO METABOLIC PRODUCTS OF MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hyperpigmentation in ectopic Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Necrolytic migratory erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pancreatic panniculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Generalized dermal melanosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PARANEOPLASTIC PROLIFERATIVE DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Acanthosis nigricans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3208461\">",
"      Sign of Leser-Trelat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Palmar hyperkeratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Tripe palm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Bazex's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3208716\">",
"      Hypertrophic osteoarthropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3208324\">",
"      PARANEOPLASTIC INFLAMMATORY DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3208878\">",
"      Sweet syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3209272\">",
"      Dermatomyositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Erythroderma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3208263\">",
"      Erythema gyratum repens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3208826\">",
"      PARANEOPLASTIC BULLOUS DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Paraneoplastic pemphigus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2292429\">",
"      Anti-epiligrin cicatricial pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      OTHER PARANEOPLASTIC DERMATOSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3209055\">",
"      Acquired ichthyosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hypertrichosis lanuginosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Xanthomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Scleromyxedema and scleredema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3209395\">",
"      Multicentric reticulohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11694078\">",
"      HERITABLE CONDITIONS ASSOCIATED WITH MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11693911\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/7606\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7606|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?4/63/5119\" title=\"diagnostic image 1A\">",
"      Pulmonary osteoarthropathy I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/43/10942\" title=\"diagnostic image 1B\">",
"      Pulmonary osteoarthropathy II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7606|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/58/43951\" title=\"figure 1\">",
"      Clubbing of the fingers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7606|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/3/15415\" title=\"picture 1A\">",
"      Necrolytic migratory erythema perioral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/32/34310\" title=\"picture 1B\">",
"      Necrolytic migratory erythema perineum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/32/17925\" title=\"picture 1C\">",
"      Necrolytic migratory erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/49/8984\" title=\"picture 2\">",
"      Systemic AL amyloidosis purpura",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/60/7107\" title=\"picture 3\">",
"      Systemic AL amyloidosis macroglossia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/61/17364\" title=\"picture 4A\">",
"      Acanthosis nigricans neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/31/4598\" title=\"picture 4B\">",
"      Acanthosis nigricans - axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/43/15030\" title=\"picture 4C\">",
"      Acanthosis nigricans - close view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/42/26272\" title=\"picture 5\">",
"      Tylosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/59/15283\" title=\"picture 6\">",
"      Tripe palm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/54/19300\" title=\"picture 7A\">",
"      Acrokeratosis paraneoplastica - multiple sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/42/3749\" title=\"picture 7B\">",
"      Acrokeratosis paraneoplastica hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/62/15333\" title=\"picture 7C\">",
"      Acrokeratosis paraneoplastica elbow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/7/19570\" title=\"picture 8A\">",
"      Hypertrophic osteoarthropathy 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/40/26242\" title=\"picture 8B\">",
"      Hypertrophic osteoarthropathy 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/11/1204\" title=\"picture 9A\">",
"      Sweet syndrome facial lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/12/25794\" title=\"picture 9B\">",
"      Sweet syndrome plaque",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/52/41806\" title=\"picture 10\">",
"      Sweet syndrome II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/45/44754\" title=\"picture 11A\">",
"      Gottron papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/6/29793\" title=\"picture 11B\">",
"      Dermatomyositis - heliotrope eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/10/29860\" title=\"picture 11C\">",
"      Dermatomyositis - heliotrope eruption on eyelid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/58/13217\" title=\"picture 11D\">",
"      Dermatomyositis - neck and chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/61/24532\" title=\"picture 11E\">",
"      Dermatomyositis dilated capillary loops",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/42/11939\" title=\"picture 12\">",
"      Adult T-cell lymphoma erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/54/10082\" title=\"picture 13A\">",
"      Erythema gyratum repens lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/15/13552\" title=\"picture 13B\">",
"      Erythema gyratum repens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/1/22546\" title=\"picture 13C\">",
"      Erythema gyratum repens 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/26/6562\" title=\"picture 14\">",
"      Paraneoplastic pemphigus oral findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/58/4004\" title=\"picture 15A\">",
"      Acquired ichthyosis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/14/11489\" title=\"picture 15B\">",
"      Acquired ichthyosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/17/44319\" title=\"picture 16\">",
"      Hypertrichosis lanuginosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/51/42800\" title=\"picture 17\">",
"      Paraneoplastic plane xanthomas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/17/35090\" title=\"picture 18\">",
"      Multicentric reticulohistiocytosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/31/41459\" title=\"picture 19\">",
"      Papules in Cowden syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/16/17666\" title=\"picture 20\">",
"      Peutz-Jeghers syndrome lip pigmentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/7606|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/50/13099\" title=\"table 1\">",
"      Curth postulates",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/37/18009?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/15/27897?source=related_link\">",
"      Acanthosis nigricans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/55/26489?source=related_link\">",
"      Causes and pathophysiology of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/60/4041?source=related_link\">",
"      Clinical course and management of monoclonal gammopathy of undetermined significance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34986?source=related_link\">",
"      Clinical features and diagnosis of primary hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=related_link\">",
"      Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22794?source=related_link\">",
"      Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/22/25960?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/25/23962?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/58/20393?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/17/8474?source=related_link\">",
"      Clinical presentation and management of thymoma and thymic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=related_link\">",
"      Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43095?source=related_link\">",
"      Diagnosis and differential diagnosis of systemic sclerosis (scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22282?source=related_link\">",
"      Epidemiology and clinical manifestations of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32250?source=related_link\">",
"      Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15578?source=related_link\">",
"      Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/31/31225?source=related_link\">",
"      Establishing the cause of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4345?source=related_link\">",
"      Evaluation of adults with cutaneous lesions of vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4088?source=related_link\">",
"      Eyelid lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=related_link\">",
"      First-line chemotherapy for patients with extensive stage small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=related_link\">",
"      Gardner syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/57/31640?source=related_link\">",
"      Glucagonoma and the glucagonoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=related_link\">",
"      Hereditary kidney cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/26/6569?source=related_link\">",
"      Inherited susceptibility to melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35496?source=related_link\">",
"      Malignancy and rheumatic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38566?source=related_link\">",
"      Malignancy in dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/7/7285?source=related_link\">",
"      Metabolic and inherited diseases affecting the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43240?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37990?source=related_link\">",
"      Overview of Peutz-Jeghers syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/34/553?source=related_link\">",
"      Overview of benign lesions of the skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/63/1016?source=related_link\">",
"      Overview of the treatment of Cushing's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=related_link\">",
"      PTEN hamartoma tumor syndrome, including Cowden syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/14?source=related_link\">",
"      Paget disease of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/45/17112?source=related_link\">",
"      Panniculitis: Recognition and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18121?source=related_link\">",
"      Paraneoplastic pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=related_link\">",
"      Pathobiology and staging of small cell carcinoma of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/28/24007?source=related_link\">",
"      Pathogenesis and causes of hirsutism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/27/44472?source=related_link\">",
"      Pathology of exocrine pancreatic neoplasms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=related_link\">",
"      Recognition of monoclonal proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40905?source=related_link\">",
"      Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_18_21803="ECG features of MI";
var content_f21_18_21803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Features of electrocardiogram that increase the probability of a myocardial infarction in patients presenting with acute chest pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Likelihood ratio",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\" colspan=\"2\">",
"       ST-segment elevation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       New",
"      </td>",
"      <td class=\"sublist_other\">",
"       6-54*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Any",
"      </td>",
"      <td class=\"sublist_other\">",
"       11",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\" colspan=\"2\">",
"       Q-waves",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       New",
"      </td>",
"      <td class=\"sublist_other\">",
"       5-25*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Any",
"      </td>",
"      <td class=\"sublist_other\">",
"       4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       New conduction defect",
"      </td>",
"      <td>",
"       6",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       ST-segment depression",
"      </td>",
"      <td>",
"       3-5*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T-wave inversion",
"      </td>",
"      <td>",
"       2-3*",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     *In heterogeneous studies the likelihood ratios are repeated as ranges.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Panju, AA, Hemmelgarn, BR, Guyatt, GH, Simel, DL. JAMA 1998; 280:1256.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21803=[""].join("\n");
var outline_f21_18_21803=null;
var title_f21_18_21804="Hydrocarbon containing products";
var content_f21_18_21804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Household products containing hydrocarbon and covered by the poison prevention packaging standard of the consumer product safety commission",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Cosmetics*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Baby oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hair oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Body oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bath oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Massage oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sunscreens",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Nail enamel dryers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Makeup removers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Automotive chemicals*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gasoline additives",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Fuel injection cleaners",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carburetor cleaners",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Cleaning solvents*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Wood oil cleaners",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Spot removers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metal cleaners",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            General-use household oils",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Adhesive removers",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Gun-cleaning solvents containing kerosene",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Other*",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Water repellents containing mineral spirits used for decks, shoes, and sports equipment",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * CPSC requires child-resistant packaging for low viscosity products that contain &ge;10 percent hydrocarbon by weight",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Barone, S. Consumer Product Safety Review. 2002; 6:3. (www.cpsc.gov/cpscpub/pubs/cpsr_nws23.pdf).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21804=[""].join("\n");
var outline_f21_18_21804=null;
var title_f21_18_21805="Comorbid conditions of urinary incontinence";
var content_f21_18_21805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F81958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F81958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comorbid conditions that may cause or worsen urinary incontinence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Comorbidity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect on continence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Cardiovascular disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arteriovascular disease",
"       </td>",
"       <td>",
"        Detrusor underactivity or areflexia from ischemic myopathy or neuropathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Heart failure",
"       </td>",
"       <td>",
"        Nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gastrointestinal disease",
"        </strong>",
"       </td>",
"       <td>",
"        Impaired emptying from impaction; fecal and urinary incontinence commonly coexist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Insomnia",
"        </strong>",
"       </td>",
"       <td>",
"        Nocturia associated with awakenings from poor sleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Metabolic diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diabetes mellitus",
"       </td>",
"       <td>",
"        DO with urge UI; detrusor underactivity due to neuropathy osmotic diuresis; altered mental status from hyper- or hypoglycemia; constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypercalcemia",
"       </td>",
"       <td>",
"        Diuresis, altered mental status",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vitamin B",
"        <sub>",
"         12",
"        </sub>",
"        deficiency",
"       </td>",
"       <td>",
"        Impaired bladder sensation and impaired detrusor contractility from peripheral neuropathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Musculoskeletal disease",
"        </strong>",
"       </td>",
"       <td>",
"        Mobility impairment; DO from cervical myelopathy in rheumatoid arthritis and osteoarthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Neurologic conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cerebrovascular disease, stroke",
"       </td>",
"       <td>",
"        DO with urge UI from decreased central control of urgency and bladder sensation; impaired function and cognition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Delirium",
"       </td>",
"       <td>",
"        Impaired function and cognition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dementia (advanced)",
"       </td>",
"       <td>",
"        Impaired cognition and function, urge UI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Multiple sclerosis",
"       </td>",
"       <td>",
"        DO, areflexia, or sphincter dyssynergia (dependent on level of spinal cord involvement)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Normal-pressure hydrocephalus",
"       </td>",
"       <td>",
"        DO from compression of frontal inhibitory centers; impaired function and cognition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Parkinson's disease",
"       </td>",
"       <td>",
"        Impaired function and cognition; constipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Restless leg syndrome",
"       </td>",
"       <td>",
"        Nocturia associated with awakenings from poor sleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spinal cord injury",
"       </td>",
"       <td>",
"        DO, areflexia, or sphincter dyssynergia (dependent on level of injury)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spinal stenosis",
"       </td>",
"       <td>",
"        DO from damage to detrusor upper motor neurons (cervical stenosis); DO or areflexia (lumbar stenosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Obstructive sleep apnea",
"        </strong>",
"       </td>",
"       <td>",
"        Nocturnal polyuria and impaired sleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Peripheral venous insufficiency",
"        </strong>",
"       </td>",
"       <td>",
"        Nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Pulmonary disease",
"        </strong>",
"       </td>",
"       <td>",
"        Chronic cough worsening stress UI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Psychiatric disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Affective and anxiety disorders",
"       </td>",
"       <td>",
"        Decreased motivation; strong association between UI and depression; nocturia associated with awakenings from poor sleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcoholism",
"       </td>",
"       <td>",
"        Functional and cognitive impairment; rapid diuresis and retention in acute intoxication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psychosis",
"       </td>",
"       <td>",
"        Functional and cognitive impairment; decreased motivation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DO: detrusor overactivity; UI: urinary incontinence.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: DuBeau CE. Urinary Incontinence. In: Geriatric Review Syllabus: A Core Curriculum in Geriatric Medicine, 7th ed, Pacala JT and Sullivan GM, eds. New York: American Geriatrics Society, 2010. Copyright &copy; 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21805=[""].join("\n");
var outline_f21_18_21805=null;
var title_f21_18_21806="Rocky mountain wood tick";
var content_f21_18_21806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68829&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    An adult female Dermacentor andersoni (rocky mountain wood tick)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 222px; height: 190px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Champman, AS, Bakken, JS, Folk, SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever, Ehrlichoioses, and Anaplasmosis-United States: A practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21806=[""].join("\n");
var outline_f21_18_21806=null;
var title_f21_18_21807="Aspergillus cortical infarct with hematoma";
var content_f21_18_21807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aspergillus cortical infarct with hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    58-year-old man with a kidney transplant. Unenhanced CT scan shows hematoma complicating a cortical infarct in left frontal lobe. Note intraventricular extension of hemorrhage. Autopsy showed Aspergillus thrombosis and vascular invasion. The patient died before cerebral angiography could be performed; a mycotic aneurysm could not be identified at autopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994; 162:155. Reprinted with permission from: the American Journal of Roentgenology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_18_21807=[""].join("\n");
var outline_f21_18_21807=null;
